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11 Introduction
The Signal Regulatory Proteins (SIRPs) are a family of transmembrane
glycoproteins that recently entered the field of signal transduction.  One subtype of
the SIRP family, SIRP α, exerts a negative influence on signal transduction
through receptor tyrosine kinases (RTK) by its association with certain
phosphotyrosine phosphatases and possibly tyrosine kinases1.  This negative
regulation may have a tumour-suppressive effect and is therefore of considerable
medical interest.  It has come to light that SIRPs constitute a family that is in turn a
member of the Inhibitory Receptor Superfamily, which has been primarily studied
from an immunological perspective.  Since SIRP family members are also
expressed in many non-haematopoietic cell types, they take the concept of
inhibitory receptors out of the immune system and into the realm of general signal
transduction.  For reviews on existing inhibitory receptor superfamily members and
mechanisms, see 2-9.  While SIRP family members are certainly related to a
number of immune receptor families, they are also analogous to members of the
ubiquitously-expressed carcinoembryonic antigen (CEA) superfamily.  The CEA
superfamily includes the biliary glycoproteins (BGP) and the C-CAM family of cell
surface adhesion molecules.  Despite sharing structural homology with these
families, SIRPs have not yet been shown to have the capacities to act as adhesion
molecules.  For a current review concerning the CEA superfamily, see
Hammarstrom (1999)117.
1.1 Structural characteristics of the SIRP α and β subtypes
The SIRP family currently numbers more than 15 closely related members among
which there exists variation in the form of subtle amino acid differences in their
extracellular domains.  The conservation is extremely high between different family
members of the same subtype and in the extracellular domain the sequences of
the alpha and beta subtypes is almost as highly conserved.  The family can
additionally be divided into two structurally distinct subtypes designated SIRP α
and SIRP β that differ by the presence or absence of an intracellular domain,
respectively.  Figure 1 depicts a protein sequence comparison of two members of
2the SIRP α subtype, SIRP α1 and SIRP α2, and one member of the SIRP β
subtype, SIRP β1.
 
Figure 1, Amino acid comparison of the primary protein sequences of SIRP α1, SIRP α2, and
SIRP β1.  Identically matching protein sequence is shown in dark grey.
The SIRP α subtype has an apparent molecular weight of between 85 and 90 kDa
in humans and rats and 110-120 kDa in the mouse.  SIRP αs are extensively
glycosylated and have either three or one immunoglobulin (Ig) -like domains.  A
single transmembrane domain separates the extracellular region from a
cytoplasmic domain of approximately one hundred amino acids containing four
3tyrosines, three of which conform to the current ‘immunoreceptor tyrosine-based
inhibitory motif’ (ITIM) consensus, ‘V/I/L/SxYxxL/V/I/S’10.  ITIMs are present in a
large group of molecules that negatively regulate cell functions.  Treatment of cells
with a variety of receptor stimuli phosphorylates the tyrosines in the ITIM and
provides a binding site for SH2 domains often belonging to a tyrosine phosphatase
(see later).  A proline-rich region near the C-terminus of SIRP α may represent a
binding site for SH3 domain-containing molecules 1,11. SHPS-1, p84, BIT, MFR and
MyD-1 are all SIRP α family members that have been discovered by other groups
1,12-17.  For simplicity, all these molecules shall be referred to here as SIRP α.
The shorter subtype, SIRP β, is more than 90% identical to SIRP α in its
extracellular domain excluding the signal peptide and has an apparent molecular
weight of 50-55 kDa.  However, SIRP β possesses a dissimilar transmembrane
domain with a positively charged lysine residue and has no significant intracellular
region.
4Figure 2  Structural characterisation of the SIRP family.  The SIRP family consists of two
structural subtypes that differ by the presence or absence of an intracellular domain.  The SIRP α
subtype possesses a long cytoplasmic domain with a proline-rich region near the C-terminus and
two ITIM motifs that can bind SH2 domain-containing phosphatases.  SIRP β has an unusual
transmembrane domain  containing a charged amino acid, but has no cytoplasmic domain.
1.2 Extracellular domain – structure and ligands
The extracellular domain of the SIRPs can have three Ig-like domains. The N-
terminal Ig-like domain is of the Ig V-type and the majority of the sequence
variation between different members of the same subtype lies in this region. The
second and third domains are of the Ig C1 type and are encoded by an exon that
may be removed by alternative splicing1,12,15,18,19.  Ig-like domains usually indicate
the extracellular association between one or more ligands, so it is likely that the
SIRPs have binding partners outside the cell.
5SIRPs are usually highly glycosylated.  The putative N-glycosylation motif (NXS/T)
is present 15 times in mouse 15, five times in human SIRP α and 6 times in human
SIRP β.  One likely reason for the difference in size seen in SDS-PAGE between
mature full-length SIRP α proteins of different species is that they are glycosylated
to varying degrees. The pattern of glycosylation is probably necessary for
molecular recognition (see below) and may produce altered ligand specificity
between SIRP α and SIRP β.
1.3 Distribution of SIRPs among tissue and cell types
SIRP α molecules are expressed in a variety of tissue types and at different levels.
Two transcripts of 4.4 and 2.4 kB have been detected by Northern hybridisation in
heart, brain, placenta, lung, liver, spleen and spinal cord19,20.  RNAse protection
analysis also reveals evidence of two transcripts20.  These two transcripts probably
reflect the two known variants generated by alternative splicing.
SIRP α protein is highly expressed in myeloid cells16,20,21.  Macrophages may
constitute a useful experimental system because they express a single SIRP α far
more predominantly than other members15,20,22-24.  High levels of SIRP α protein
are also seen in neurons and specific areas of the brain13,18,19,25.  In Western blot,
one study collectively detected proteins at 120, 85-95, 50 and 42 kDa in different
tissues and cell lines20. Following enzymatic deglycosylation, only two bands at 65
and 35 kDa are detectable1,20.  Glycosylation is therefore probably critical for
determining a repertoire of roles for different family members.
Approaches using detection with monoclonal antibodies have been informative but
occasionally misleading by suggesting that expression is highly restricted to certain
tissues.  This is probably because the antibody is sensitive to a certain
glycosylation pattern15.  SIRP α glycosylation therefore is likely to vary between
cell types and may reflect potential ligand binding sites being masked or created.
For some reason, it is very difficult to detect expression of endogenous
SIRP β molecules at the transcriptional level by Northern blot or at the protein level
by Western blot.  Despite these difficulties, SIRP β was detected in myeloid cells
by Western blot and can be readily amplified from cDNA isolated from a variety of
6epithelial and haematopoietic cell lines.  Additionally, numerous members of the
SIRP β subtype were obtained from a cDNA library screen in a multitude of cell
lines (Kharitonenkov et al. and Sures, unpublished observation), proving their
endogenous expression.
1.4 Induction of SIRP α tyrosine phosphorylation
There are a variety of different stimuli that result in tyrosine phosphorylation of
SIRP α.  These include EGF, PDGF, insulin, neurotrophins, G-protein coupled
receptors, adhesion to fibronectin, growth hormone, colony stimulating factor and
serum 1,12,22,26-33.  SIRP α tyrosine phosphorylation is also induced by light in the
suprachiasmatic nucleus of the brain and may therefore be involved in modulating
the circadian rhythm34.  The only ligands known so far to be unable to elicit SIRP α
tyrosine phosphorylation are leukaemia inhibitory factor and interferon γ, shown in
fibroblasts 31.  This large list of receptors includes examples with and without
kinase activity, and the mechanisms by which they may transduce a signal are
often very different. This begs some kind of standardisation between the manner or
mechanism by which SIRP α tyrosine phosphorylation is triggered.  Here, a system
is proposed that funnels the receptor stimulus through a bottleneck involving
cytosolic tyrosine kinases.
Tyrosine phosphorylation of SIRP α following insulin stimulation of RAT1-IR cells
occurs mainly on the last two tyrosines (Y449 and Y 473)35.  Mutating either of
these tyrosines abolishes most of the tyrosine phosphorylation of SIRP α and its
association with SHP-2.  Which tyrosines become phosphorylated may vary
depending on the nature of the stimulation.
1.5 Association of SIRP α with tyrosine phosphatases
Possibly the best characterised effect of SIRP α tyrosine phosphorylation is its
strong association with either of the two SH2 domain-containing tyrosine
phosphatases SHP-1 and SHP-21,20,22 which is mediated by the SH2 domains of
the phosphatase and the phosphorylated ITIMs of SIRP α35.  Binding stimulates
the catalytic activity of the phosphatase while, perhaps paradoxically, SIRP α
7molecules are also substrates of these phosphatases1,22,27,29,35.  Structural data
following the crystallisation of SHP-2 reveals that the binding of the N-terminal SH-
2 domain regulates the phosphatase activity while the C-terminal domain plays an
accessory role36.  Although two molecules of SHP-2 can bind in vitro to one
molecule of tyrosine phosphorylated SIRP α14,a binding (which would saturate the
tyrosines), other SH2 domain-containing proteins such as Grb2 and CSK can also
bind to SIRP α1,20.  A situation where proteins are heterogeneously clustered
around SIRP α would make a mechanistic signalling complex easier to conceive.
Despite having a similar structure, SHP-1 and SHP-2 appear to possess different
biological functions, SHP-1 having an inhibitory role and SHP-2 seemingly the
opposite (reviewed in37,38).  One function of tyrosine phosphorylated SIRP α in
haematopoietic cells may be to direct SHP-1 to a receptor e.g. the CSF-1R22,
where it dephosphorylates target members of the complex.  An explanation for
SHP-2 association is less clear.  Recruitment to SIRP α from the cytosol to the
membrane following stimulation28,35 may sequester SHP-2 away from areas where
it has a positive effect.  SHP-2 could activate proteins by dephosphorylation of src-
family kinases as has been recently suggested39 because the SH3 domain of c-src
associates with SHP-2 that dephosphorylates Y527 in vitro40.  The SH3 domain
binding explains why overexpression of SHP-2 causes an increase in c-src activity
that is independent of SHP-2 catalytic activity, dephosphorylation of Y527 not
being observed41.  This may have been different if the system had involved SIRP α
binding to activate SHP-2.
SIRP α may rely on other proteins for negative signalling that associate in a
tyrosine phosphorylation-dependent manner (see later).  Dephosphorylation of
SIRP α by SHP-2 would dismantle such a negative signalling complex.
1.6 Involvement of protein tyrosine kinases in SIRP α
signalling
Endeavours have been made to identify the kinase or kinases responsible for
direct tyrosine phosphorylation of SIRP α.  Tyrosine phosphorylation of SIRP α
occurs as early as one minute after stimulation of cells with EGF or PDGF1.
8Additionally, purified EGFR28 and semi-purified IR27 can phosphorylate SIRP α in
vitro. Therefore, following EGF, PDGF or insulin stimulation of cells, the respective
receptors are either directly responsible for tyrosine phosphorylation, or the kinase
responsible is an intimate part of the complex.
However, SIRP α is also tyrosine phosphorylated after stimulation of receptors
without tyrosine kinase activity.  Stimulation of integrins by adhesion of cells to
fibronectin leads to SIRP α tyrosine phosphorylation after 15 minutes 33,39.  This
tyrosine phosphorylation is reduced when cell lines where c-src, fyn or FAK are not
expressed and in cell lines overexpressing CSK, a tyrosine kinase that inhibits src
family kinases by phosphorylating Y527, a regulatory tyrosine present at the
C-terminus (for reviews, see 42,43).  C-src but not FAK, phosphorylates SIRP α in
vitro33.  Similar effects on SIRP α tyrosine phosphorylation are seen with
lysophosphatidic acid (LPA), which stimulates cells through G protein-coupled
receptors (GPCRs) 30.  It is important to note that examples of ligand-independent
RTK stimulation following activation of integrins or GPCRs are both documented
44,45, therefore SIRP α could be phosphorylated following RTK activation by a form
of lateral signalling.
Stimulation of cells with growth hormone (GH) leads to SIRP α tyrosine
phosphorylation.  The GH receptor has no intrinsic tyrosine kinase activity and
signalling through the GH receptor is expected to be mediated by the cytosolic
tyrosine kinase JAK2.  Stofega et. al46 propose that JAK2 phosphorylates SIRP α
since it is able to in vitro. Furthermore, JAK2 is present in a complex with SIRP α
when both JAK2 and SIRP α are overexpressed, an association, which requires
neither the C-terminally, located proline-rich region of SIRP α nor SIRP α tyrosine
phosphorylation46.  Moreover, both JAK2 and SIRP α associate directly with
SHP-231. Lastly, overexpression of SIRP α negatively regulates GH-induced
phosphorylation of MAP kinase and STAT family members.
Two further cytosolic tyrosine kinases are relevant to SIRP α.  CSK associates
endogenously with SIRP α 20 in macrophages but the physiological significance is
unclear.  SIRP α may downregulate signalling through CSK by the inhibition of src-
family PTKs.
9PYK2, a cytosolic tyrosine kinase related to FAK, was recently shown to be
present in an in vivo complex with SIRP α in mouse macrophages.  PYK2
represented a significant proportion of the kinase activity in this complex23.
Whether or not CSK and PYK2 are relevant to SIRP α tyrosine phosphorylation,
they are likely to be participants in SIRP-related signalling.
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Figure 3  The SIRP α subtype: known interactors and its putative influence upon signal
transduction.  The diagram depicts proteins thought to be physically associated with either
SIRP α proteins.  A number of cytosolic tyrosine kinases cluster around SIRP α as well as two
adaptor proteins  (‘Role of SIRPs in biological processes’, see later).
Stimulation of a variety of receptors results in SIRP α tyrosine phosphorylation,
thought to be catalysed by cytosolic tyrosine kinases. The consequent binding and
activation of SHP-2 is necessary for an inhibitory effect upon the signalling
generated by this stimulus.
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1.7 Role of SIRPs in biological processes
NIH3T3 cells overexpressing SIRP α grow more slowly than mock infected cells
and are resistant to focus formation and growth following transformation by v-fms.
Furthermore, MAP kinase activation is inhibited following EGF or insulin stimulation
in these cells1. On the other hand, a positive effect of SIRP α on MAP kinase
activation has been reported following insulin stimulation28.
SIRP α expression increases during macrophage fusion.  Additionally,
macrophage fusion is inhibited by the addition of mAb against SIRP α15.  Similar
experiments show that mAb against SIRP α inhibit the migration of neutrophils
through endothelium21.  In neuronal cells, SIRP α is documented as an adhesion
molecule and implicated in neuronal outgrowth and axon guidance13.  SIRP α
molecules may therefore be relevant to macrophage fusion, cell migration or the
navigation of neurons during development, but these findings, taken together with
the wide tissue expression of SIRP α, suggest that their role is more fundamental,
perhaps lying in specific intercellular recognition.
1.8 SIRP β:  A counterpart of SIRP α?
Researchers have invested a considerable amount of work and time to understand
SIRP α, its profile of expression, associated proteins, mechanism of action and
biological function.  As a consequence, much is known about the function of
SIRP α as a molecule with dual influence on signal transduction and the possible
coordination of cellular movements.  During this intensive phase of investigation
however, research on the SIRP β subtype was neglected.  Very little was
discovered about any signalling mechanisms involving SIRP β or any role it had in
these or other cellular processes.  There may be understandable reasons for this;
SIRP β, unlike SIRP α, has no intracellular domain, and cannot therefore be
tyrosine phosphorylated.  Additionally, the subtype has an apparent MW (55kDa) in
SDS PAGE that is the same as that of antibody heavy chains, making it very
difficult to reveal through immunoprecipitation experiments.  Taken together, one
can see that SIRP β is technically a particularly difficult molecule to work with.
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Nevertheless, multiple copies of cDNAs encoding for proteins of the
SIRP β subtype have been found from cDNA library screens, and, although less
strongly expressed, SIRP β can be amplified from cDNA obtained from cell lines
and tissue (I.Sures, personal communication)1.  The strong similarity of SIRP β to
SIRP α throughout large regions of the protein sequence (Figure 1) may relate it to
SIRP α mechanistically and also functionally.  SIRP β may complement or oppose
SIRP α in its function.  Indeed, the two subtypes may constitute two halves of the
same system, and in this case an understanding of SIRP β function would be
essential to understand the overall contribution of the family to the biology of an
organism.
The actions of the SIRP family suggests that modulation of receptor stimuli by
inhibitory receptors may be a fundamental concept in mammalian signal
transduction. In B cells and T cells, antigen receptor signalling is controlled by
coreceptors recruiting cytosolic complexes in response to stimulation with antigen.
The inhibitory receptor superfamily had been thought to be specific to the immune
system but SIRPs show that this concept applies not only to antigen receptors, but
also to receptor tyrosine kinases, cytokine receptors, G protein-coupled receptors,
integrins and other membrane receptor systems.  It seems, however, that
immunology provides an increasingly valuable source of analogy to which we can
look for inspiration.
1.9 Objectives
Knowledge about the SIRP family is limited to a window focussed upon the
signalling of the intracellular domain of SIRP α.  This work plans to expand it to
encompass the extracellular region of SIRP α as well as the complete SIRP β
molecule to build an understanding of the function of the whole family.
The role of SIRP α to regulate signal transduction and cellular transformation
through receptor tyrosine kinase (RTK) signalling is known.  Other molecules
participating in the system could however be revealed by experiments with
inhibitors of different signal transduction molecules.  This would help to clarify how
SIRP α is activated by a receptor.
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The extracellular domain of the SIRPs has not been studied, although it comprises
more than half of the molecule and always contains at least one Ig-like domain.  In
other molecules, Ig-like domains are often binding sites for ligands.  Examining the
extracellular domains for their cell-binding affinity would establish and identify new
molecules that might associate with the extracellular domain of the two subtypes.
Knowledge of these binding proteins could clarify the context of SIRP α signalling.
A ligand common to both SIRP α and SIRP β, would possibly point to a common
function.
SIRP α is known to be present at the cell membrane, to recruit other molecules to
the membrane and to associate with receptors.   To learn whether the
SIRP β molecules had a similar localisation, perhaps within specific subcellular
compartments, a combination of fluorescence microscopy and cellular fractionation
techniques could be used.
To investigate the possible role of SIRP β1 in signal transduction, its binding
partners needed to be identified using appropriate In vitro association experiments.
Assays of tyrosine phosphorylation and catalytic activity would then be necessary
to reveal evidence of signalling by SIRP β-associated molecules.  Within this
context, coexpression of SIRP α might reveal an influence upon this signalling.
To identify a biological function for SIRP β, different cellular assays could be
performed upon cell lines stably overexpressing parts of the SIRP β complex.
14
2 Abbreviations Used
α anti-
aa amino acid
Ab antibody
aa amino acid
AP alkaline phosphatase
ATP adenosine triphosphate
bp base pair
BSA bovine serum albumin
BCR B cell receptor
cDNA complementary DNA
CIP calf intestine phosphatase
CMV cytomegalovirus
Coom. Coomassie
CSK c-src kinase
ddH2O doubly distilled water
DAG diacylglycerol
DAPI 4´,6-diamidino-2-phenylindole
DMSO dimethyl sulfoxide
DAP12 DNAX activating protein 12
dNTP deoxynucleotide triphosphate
DTT dithiothreitol
DNA deoxyribonucleic acid
EDTA ethylenediaminetetraacetic acid
ER Endoplasmic reticulum
EGF epidermal growth factor
ex extracellular (domain)
FAK focal adhesion kinase
PDGF platelet-derived growth factor
GFP Green Fluorescent Protein
GH growth hormone
GST glutathione-S-transferase
GPI glycophosphotidyl inositol
GPCR G-protein-coupled receptor
HRP horseradish peroxidase
h human
hr hour
Ig Immunoglobulin
IR insulin receptor
IRES internal ribosomal entry site
ITAM immunoreceptor tyrosine-based
activation motif
ITIM immunoreceptor tyrosine-based
inhibition motif
JAK JAnus Kinase
JnK c-jun kinase
kB kilobase
kDa kiloDalton
KIR killer inhibitory receptor
IAP integrin associated protein
IRES Internal ribosomal entry site
LB Luria-Bertani Medium
LPA lysophosphatidic acid
LTR long terminal repeats
MAPK mitogen activated protein kinase
mAb monoclonal antibody
2-ME 2-mercaptoethanol
MCS multiple cloning site
MW molecular weight
mRNA messenger RNA
OD optical density
ORF open reading frame
PAGE polyacrylamide gel electrophoresis
PBS phosphate buffered saline
PCR polymerase chain reaction
PEG polyethylene glycol
PI-3K phosphoinositide 3-kinase
PLC phospholipase C
PoV sodium pervanadate
RNA ribonucleic acid
RT room temperature
RTPCR reverse transcriptase PCR
RTK receptor tyrosine kinase
SDS sodium dodecyl sulphate
sec second
SIRP signal regulating protein
STAT signal tranducer and activator of
transcription
TAE Tris acetate buffer
TBS Tris buffered saline
TCR T-cell receptor
TNFα tumour necrosis factor alpha
Tm melting temperature
Tris-Cl Tris hydrochloride
U unit of enzymatic activity
UV ultraviolet
v/v volume-per-volume
PLIC ‘proteins linking IAP to the
cytoskeleton47’
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3 Materials
3.1 Antibodies
The following primary antibodies were used either in immunoprecipitation or as
primary antibodies in immunoblot or immunofluorescence analysis:
Antibody Comments Source
α-SIRP α ex(ExC2) Affinity purified antiserum recognizing Self-Made
 the extracellular domain of SIRP α 1
α-SIRP β ex Affinity purified antiserum recognizing Self-Made
 the extracellular domain of SIRP β 1
α-SIRP ex (ExF1) Polyclonal antiserum recognising Z.Chen1
both SIRP α and SIRP β extracellular
domains
B1D5C3 mAb selectively recognising the Dr. H-J
extracellular domain of SIRP β1 Bühring,
without recognising SIRP α1, used in Tübingen
stimulation experiments and
immunofluorescence
4G10 anti-phosphotyrosine mAb UBI, USA
The following HRP-conjugated secondary antibodies were used in conjunction with
the ECL kit to visualize proteins in immunoblot (Western blot) analysis:
Antibody Dilution Source
Goat anti-Mouse 1: 20000 BioRad (Munich)
Goat anti-Mouse 1: 10000 Sigma (Munich)
Goat anti-Rabbit 1: 20000 BioRad (Munich)
Goat anti-mouse antibody coupled to the Cy3 Fluorophore (Molecular Probes,
Leiden, Netherlands) was used in a 1:1000 dilution to visualize cellular
immunostaining with mAb B1D5C3.
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3.2 Chemicals, enzymes and commercial kits
3.2.1 Chemicals
Acrylamide National Diagnostics, Atlanta, USA
Agar Difco, Detroit, USA
Agarose Gibco BRL, Eggenstein, Germany
Ammonium persulphate Serva, Heidelberg, Germany
Ampicillin Roche, Mannheim, Germany
Aprotinin Sigma, Munich, Germany
ATP Pharmacia, Freiburg, Germany
BES (N,N-Bis (2-Hydroxyl) Sigma, Munich, Germany
2-amino-ethanesulphonic acid Roth, Karlsruhe, Germany
Bis-acrylamide National Diagnostics, Atlanta, USA
Bromophenol blue Sigma, Munich, Germany
BSA (bovine serum albumin)Sigma, Munich, Germany
Coom. G250 Brilliant Blue Serva, Heidelberg, Germany
Cell culture plasticware Greiner, Solingen
Nunc, Denmark
Falcon, UK
DNA-size marker Eurogentec, Cologne, Germany
DTT Sigma, Munich, Germany
EDTA Baker Chemicals, Deventer, NL
Ethidium Bromide Sigma, Munich, Germany
Formamide Fluka AG, Neu-Ulm, Germany
G418 (Geneticin) Gibco BRL, Eggenstein, Germany
Glutathione-Sepharose Pharmacia, Freiburg, Germany
HEPES (4-(2-hydroxyethyl)-1 BIOMOL, Hamburg, Germany
-piperazine-ethanesulphonic acid
Hybond-N (Nylon membrane) Amersham-Buchler, Braunschweig, Germany
Lipofectamine® Gibco, Eggenstein
L-Glutamine Gibco BRL, Eggenstein, Germany
Kanamycin Roche, Mannheim, Germany
Mineral oil Sigma, Taufkirchen
MTT (3-[4,5-Dimethyltiazol-2-yl]- Sigma, Taufkirchen
2,5vDiphenyltetrazoliumbromid)
Nucleotides and Pharmacia, Freiburg, Germany
Dideoxynucleotides
PEG (polyethylene glycol) Sigma, Munich, Germany
Protein A sepharose 4B Pharmacia, Freiburg, Germany
Permafluor Molecular Probes, Leiden, Netherlands
SDS   Roth, Karlsruhe, Germany
Sodium Azide Serva, Heidelberg
Sodium Fluoride Sigma, Taufkirchen
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Sodium Orthovanadate Aldrich, Steinheim
Phenol Roth, Karlsruhe
PMSF (Phenylmethy- Sigma, Taufkirchen
lsulfonylfluoride)
Polybrene (Hexadimethrine Sigma, Taufkirchen
bromide)
Poly-Lysine Sigma, Taufkirchen
Ponceau S Sigma, Taufkirchen
Sterile filter 0.22 µm Nalge Company, USA
Sterile filter 0.45 µm Nalge Company, USA
TEMED Serva, Heidelberg, Germany
Triton X-100 Serva, Heidelberg
Tryptone Difco, Detroit, USA
Tween 20 Sigma, Taufkirchen
Tween 40 Sigma, Taufkirchen
Triton X-100 Roth, Karlsruhe, Germany
Whatmann 3MM paper Whatmann, USA
Xylol Merck, Darmstadt
X-Omat Kodak, Stuttgart, Germany
Yeast extract Difco Laboratories Detroit, USA
Unless otherwise stated chemicals were purchased from Merck, Darmstadt or from
Sigma, Munich.
3.2.2 Restriction, polymerases and modifying enzymes
Calf intestinal phosphatase Roche, Mannheim, Germany
T4 DNA Polymerase Roche, Mannheim, Germany
Klenow fragment Roche, Mannheim, Germany
T4 DNA Ligase Roche, Mannheim, Germany
RNAse A Roche, Mannheim, Germany
rTaq® DNA Polymerase Takara, Kyoto, Japan
Restriction Enzymes New England Biolabs, Schwalbach, Germany
3.2.3 Radiochemicals
[α-33P]-dATP, [γ-32P]-ATP >5000 Ci/mmol
[α-35S]-dATP >1000 Ci/mmol
All radiochemicals were purchased from NEN, Brussels, Belgium.
3.2.4 Commercial kits
Qiagen Plasmid Mini Kit, Qiagen GmbH, Hilden, Germany
Qiagen Plasmid Maxi Kit, Qiagen GmbH, Hilden, Germany
Qiaex II Gel Extraction Kit, Qiagen GmbH, Hilden, Germany
ECL Kit, NEN, Brussels, Belgium
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Micro BCA Protein Assay Kit, Pierce, USA
Poly Prep Chromatography Columns, Bio-Rad, Munich
3.3 Media and cell culture conditions
3.3.1 Medium for E.coli culture
The base for all bacterial culture unless otherwise stated was LB medium48, which
consisted of 1% tryptone, 0.5% yeast extract and 0.5% NaCl, pH 7.2. Ampicillin
was used for selection at a concentration of 50 µg/ml. All liquid medium was
solidified with 1.5% bacto-agar in order to make culture plates.
3.3.2 Bacterial culture conditions
The E.coli strains XL1-Blue and CJ236 were cultured at 37°C either on selection
plates or as liquid medium in Erlenmeyer flasks.
3.3.3 Cell culture media
Cell culture media as well as additional components were purchased from Gibco
BRL, Eggenstein, Germany, with the exception of foetal calf serum that was
purchased from Sigma.   In the case of the NIH3T3, HEK293, COS-7 and A431
cell lines, Dulbecco’s Modified Eagle Medium (DMEM) with 4.5 mg/ml Glucose,
10% FCS, 2 mM Glutamine, 1 mM sodium pyruvate was used.  All other
mentioned cell lines were cultured in medium recommended by the supplier, and
where possible, purchased from Gibco BRL (Germany).  Selection of stably
integrated cell lines was with medium containing G418 at a concentration of 1
mg/ml.  Cells were frozen for storage in 90% FCS, 10% DMSO.
3.4 Stock solutions and frequently used buffers
The stock solutions listed below were all prepared with ddH2O.  “x” refers to the
fold concentration of the stock solution.
BBS (2 x) 50 mM BES
280 mM NaCl
1.5 mM Na2HPO4
pH 6.96 (NaOH)
DNA-loading buffer (6 x) 0.25 % Bromophenol Blue
0.25 % Xylene cyanol
30 % Glycerol
100 mM EDTA pH 8.0
Src-kinase assay buffer 20 mM HEPES pH 7.4
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1 mM MnCl2
1 mM DTT
100 µM Na-Orthovanadate
50 µM ATP
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Laemmli-buffer (2 x) 187.5 mM Tris-Cl pH 6.8
6 % SDS
30 % Glycerol
0.01 % Bromophenol Blue
5 % 2-ME
mRNA binding buffer 0.5 M NaCl
10 mM Tris-Cl pH 7.5
1 mM EDTA
0.5 % SDS
mRNA elution buffer 10 mM Tris-Cl pH 7.5
1 mM EDTA
0.2 % SDS
NET/gelatine (1 x) 150 mM NaCl
5        mM EDTA
50      mM Tris
0.05 % Triton X-100
pH 7.4 (HCl)
25 mg/ml Gelatine
PBS 13.7 mM NaCl
2.7 mM KCl
80.9 mM Na2HPO4
1.5 mM KH2PO4, pH 7.4 (HCl)
PBG 0.5 % BSA
0.045 % Fish gelatine
in 1x PBS
RIPA lysis buffer 1 % NP-40
1 % Na-deoxycholate
0.1 % SDS
150 mM NaCl
50 mM Tris-Cl pH 7.5
50 mM NaF
2 mM EDTA
1 mg/ml Aprotinin
100 mM Na-Orthovanadate
SD-Transblot 50 mM Tris-Cl pH 7.5
40 mM Glycine
20 % Methanol
0.004 % SDS
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TAE (10 x) 400      mM Tris/Acetate
10        mM EDTA
pH 8.0 (Glacial Acetic Acid)
TE 10 mM Tris/HCl pH 8.0
1 mM EDTA pH 8.0
Tris-Glycine-SDS (10 x) 248 mM Tris/HCl pH 7.5
1918 mM Glycine
1.0 % SDS
Triton X-100 Lysis buffer 50 mM HEPES pH 7.5
150 mM NaCl
1.5 mM MgCl2
200 mM EGTA
50 % glycerol
0.1 % Triton X-100
1 mg/ml Aprotinin
100 mM Na-Orthovanadate
3.5 Bacterial strains
The following two E.coli strains were used in this work for cloning and in vitro
mutagenesis of plasmid DNA, respectively.
Strain  Genotype Reference
E.coli CJ236 dut-, ung-, thi-, relA- Kunkel,
198549
E.coli XL-1 Blue F’:Tn10 proA+B+ laclq D(lacZ) M15/ Stratagene,
RecA1 end/A1 gyr 96 (Nalr) thi hsdR17 USA
(rk-mk+) supE44
3.6 Cell lines
Line Origin Reference
A431 Human epidermoid carcinoma ATCC CRL-1555
BOSC Ecotropic retroviral producer line Pear (1993) 50
derived from HEK293
COS-7 Immortalised African green ATCC CRL-1651
Monkey kidney fibroblasts
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COS-7/SIRP α1 COS-7 overexpressing hSIRP α1 This work
HEK293 Human transformed kidney fibroblasts ATCC CRL-1573
Jurkat Human T-cell leukaemia J. Schlessinger
K562 Chronic Myeloid Leukaemia ATCC CCL-243
KG-1 Human myeloid leukaemia ATCC CCL-246
MCF7 Human breast adenocarcinoma ATCC HTB-22
MCF-10A Human mammary gland ATCC CRL-
10317
MEG-01 Human megakaryoblastic leukaemia ATCC CRL-2021
Melanocytes Human Clonetics,MD, USA
NIH3T3 cl.7 Immortalised Mouse Fibroblasts ATCC CRL-1658
X123 Oligoclonal NIH3T3-derived cell line this work
selected for integrated pIRES
SD469 Oligoclonal NIH3T3-derived cell linethis work
 overexpressing SIRP β and DAP12
NT2 Human testicular teratocarcinoma Stratagene
Raji Human Burkitt’s lymphoma ATCC CCL-86
U-937 Human histiocytic carcinoma ATCC CRL-1593
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3.7 Plasmids and oligonucleotides
3.7.1 Cloning vectors and constructs
3.7.1.1 Cloning Vectors
Vector Attributes Reference
pBluescript ColE1 ori, Ampr, LacZ, f1 (+) IG, Stratagene, USA
SK (MCS)
pcDNA3 Eukaryotic expression vector, Ampr, Invitrogen, USA
Neor, CMV Promoter, BGH poly A, 
F1(-) ori
pCEP4 Eukaryotic Expression Vector, Ampr, Invitrogen, USA
Hygr, CMV promoter, EBNA-1 gene,
 TK poly A
pLEN Retroviral expression vector, Miller and 
Ampr, Neor, ori from pBR322, Rosman, 1989 51 
5’-LTR and 3’-LTR from MoMuLV,
ECMV pIRES sequence.
pLXSN Retroviral expression vector, Adam, 1991 52
Ampr, Neor, ori from pBR322,
5’-LTR and 3’-LTR from MoMuLV,
SV40 Promoter
pIRES Retroviral expression vector, Derived from 
Ampr, Neor, ori from pBR322, pLXSN and 
5’-LTR and 3’-LTR from MoMuLV, pLEN
SV40 Promoter, ECMV IRES (this work)
pSj26 (mod) Eukaryotic expression vector, Ampr,Derived from CMV
Promoter, BGH poly A,            pCDNA3
Enterokinase cleavage site between (this work)
GST and fused protein, PKA labelling
site
pCDNA3 IgGFc Eukaryotic expression vector, Ampr,Derived from CMV
Promoter, BGH poly A,            pCDNA3
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(this work)
pEGFP Eukaryotic GFP fusion expression Invitrogen, USA
vector, Kanr
pGEX-2TK Bacterial GST fusion protein Pharmacia,
expression vector , Ampr, Freiburg,
Germany
pLXSN EKS Derived from pLXSN, modified to J.Ruhe (this
contain pBluescript  KS MCS. department)
3.7.1.2 Eukaryotic expression constructs used in this work
Name Expressed insert
pSj26(mod)/SIRP α1 ex hSIRP α1 ex (aa’s 1-373) -GST fusion
pSj26(mod)/SIRP α2 ex hSIRP α2 ex (aa’s 1-373) -GST fusion
pSj26(mod)/SIRP β1 ex hSIRP β1 ex (aa’s 1-369) -GST fusion
pSj26(mod)/DAP12 complete DAP12 ∆stop (aa’s 1-113)-GST
fusion
pCDNA3 IgGFc/SIRP α1 ex hSIRP α1 ex (aa’s 1-373) -IgG fusion
pCDNA3 IgGFc/SIRP α2 ex hSIRP α2 ex (aa’s 1-373) -IgG fusion
pCDNA3 IgGFc/SIRP β1 ex hSIRP β1 ex (aa’s 1-369) -IgG fusion
pCDNA3/SIRP α1 complete hSIRP α1 (aa’s 1-503)
pCDNA3/SIRP α1/Y/F hSIRP α1 Y429F Y452F Y468F Y495F
(SIRP α-4Y 1)
pCDNA3/SIRP β1 complete hSIRP β1 (aa’s 1-398)
pCDNA3/Syk complete hSyk (aa’s 1-635)
pCDNA3/Syk K/R hSyk (K402R) =kinase inactive
pCDNA3/DAP12 complete DAP12 (aa’s 1-113)
pCDNA3/c-src K/R complete c-src K297M, chicken, kinase
inactive
pCDNA3/c-fyn K/R complete c-fyn K299A, chicken, kinase
inactive
pLXSN/SIRP α1 complete hSIRP α1 (aa’s 1-503)
pLXSN/SIRP β1 complete hSIRP β1 (aa’s 1-398)
pLXSN/DAP12 complete DAP12 (aa’s 1-113)
pIRES/SIRP β1+DAP12 complete SIRP β1 and DAP12 expressed
bicistronically
pCEP4/Syk complete hSyk (aa’s 1-635)
pCEP4/Syk K/R hSyk (K402R) =kinase inactive
3.7.2 Important oligonucleotides used
Sj26(mod) f 5’ - CCG CTC GAG CGT CGT GCA TCT GTT GAT GAT GAT GAT AAG ATG
TCC CCT ATA CTA GG -3’
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Used for PCR amplification of GST from pGEX 2TK (Pharmacia, Freiburg, Germany)
Sj26 rev 5’ - GCG GGG CCC TTA TTT TGG AGG ATG GTC G -3’
For PCR amplification of GST from pGEX 2TK (Pharmacia, Freiburg, Germany)
h IgG1 f 5’ - CCG CTC GAG ATG GTC ACC GAC AAA ACT C -3’
For PCR amplification of human IgG1 heavy chain coding region from pBSSK-CH2CH3
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h IgG1 r 5’ - GCG GGG CCC TCA TTT ACC CGG AGA CAG -3’
See h IgG1 f
GP fo 5’ - CCG CTC GAG ATG GTG AGC AAG GGC GAG -3’
For PCR amplification of GFP coding region from pEGFP (Invitrogen, USA)
GP rev 5’ - GCG GGG CCC TTA CTT GTA CAG CTC GTC C -3’
See GP fo
SIRP α f 5’ - GCG GAA TTC GCC ACC ATG GAG CCC GCC GGC -3’
For amplification of coding region of human SIRP α1 or 2 from cDNA
1
SIRP α r 5’ - CGG GGA TCC TCA CTT CCT CGG GAC CTG G -3’
See SIRP α f
SIRP α1ex rev 5’ - CGG GGA TCC CCG TTC ATT AGA TCC AGT GTT CTC -3’
Used with SIRP α f for amplification of the extracellular domain of SIRP α1 or 2
Beta 1 f 5’ - GCG GAA TTC GCC ACC ATG CCC GTG CCA GCC TCC -3’
For amplification of human SIRP β1 from plasmid 54
Beta r stop 5’ - CCG CTC GAG TCA GGC CTT CTG TTT CCA GCA GAT -3’
Reverse primer used with Beta 1 f
Beta ex r 5’ - CCG CTC GAG AGC AGT AGG AGC CAG CGC -3’
Used with Beta 1 f for amplification of the extracellular domain of SIRP β1.
DAP12 f Eco R1 5’ - GCG GAA TTC GCC ACC ATG GGG GGA CTT GAA CCC TGC -3’
For amplification of human DAP12 from cDNA
DAP12 Flag r Xho1 5’ – GCG CTC GAG TCA CTT ATC ATC ATC ATC TTT GTA ATA CGG
CCT CTG TG -3’
Used together with DAP12 f Eco R1 (adds Flag epitope tag)
DAP12 rev nostop 5’ - GCG CTC GAG CTT ATC ATC ATC ATC TTT GTA ATA CGG CCT
CTG -3’
Used with DAP12 f Eco R1 to produce DAP12 for cloning into pSj26 (mod)
DAP12 f not1 5’ - GCG GCG GCC GCG CCA CCA TGG GGG GAC TTG AAC C -3’
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For amplification of human DAP12 from cDNA for cloning into pIRES
DAP12 Flag r BstX1 5’ - GCG CCA CCG CGG TGG TCA CTT ATC ATC ATC ATC TTT GTA
ATA C -3’
Used with DAP12 f not1
h Syk f 5’ -  GCG GAA TTC GCC ACC ATG GCC AGC AGC GGC ATG GC -3’
Amplification of human Syk from cDNA
mouse Syk f 5’ -  CCG CTC GAG TCA GGC CTT CTG TTT CCA GCA GAT -3’
For amplification of mouse Syk from cDNA (used with h Syk r)
h Syk r 5’ -  GGC CTC GAG TTA GTT CAC CAC GTC ATA GTA G -3’
See h Syk f and mouse Syk f
h Syk r Flag 5’ -  GGC CTC GAG TTA CTT ATC ATC ATC ATC CTT GTA ATC GTT
CAC CAC GTC ATA GTA G -3’
Used with h Syk f for production of Flag epitope-tagged Syk
h Syk k/R rev 5’ - GTT TTT CAG GAT CCT CAC AGC CAC GGT -3’
Used for production of kinase inactive Syk by in vitro mutagenesis
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4 Methods
4.1 Molecular Biology
4.1.1 Preparation and Purification of Plasmid DNA from Bacteria
The procedure was based, with modifications, on the alkaline lysis method
described by Birnboim & Doly (1979) 55.
4.1.2 Digestion of DNA with Restriction Endonucleases
Restriction digests utilised the pre-made buffers accompanying the respective
enzymes as recommended by the supplier.  In a typical analytical digest, 1 µg of
plasmid DNA was cut with 0.5 units of a given enzyme for a duration of 60 min at
37°C. Where necessary the enzyme was stabilised by addition of BSA (100 µg/ml).
4.1.3 Dephosphorylation of 5´ Termini
The removal of 5´ phosphate groups from DNA was necessary in order reduce the
efficiency of intramolecular ligation, for example to lower the efficiency of vector
self-ligation where cloning DNA fragments. Restricted DNA was therefore
incubated with one unit of CIP for 30 minutes at 37°C, and the DNA purified by
agarose gel electrophoresis.
4.1.4 Blunt Ending 3´ or 5´ Overhangs
It was occasionally necessary during cloning strategies to blunt end 3´ or 5´
overhangs. This was achieved using T4 DNA Polymerase. DNA possessing
cohesive ends was added to 100 µM of dNTP, 1-2 U polymerase/µg DNA and
incubated at 12°C for 20 minutes. Heat inactivation followed at 75°C for 10
minutes.
4.1.5 Preparation of total RNA
1g of mammalian cells from a monolayer culture were lysed and homogenised in
10 ml of a solution of 4 M guanidinium thiocyanate, 25 mM sodium citrate pH 7.0,
0.5% sarkosyl 0.1 M 2-ME and 10 mM EDTA.  To this mixture, 1 ml 2M Na-acetate
was added, and the mixture vortexed.  10 ml water-saturated phenol was then
added before the mixture was again vortexed.  The sample was centrifuged at
10,000 x g for 10 minutes.  The upper, aqueous phase was transferred to a fresh
tube and 10 ml isopropanol was added.  After a centrifugation step of 10 minutes
at 3000 x g, the supernatant was discarded and the pellet redissolved in 2 ml 4 M
LiCl.  The sample was again centrifuged at 3000 x g for 10 minutes and the pellet
redissolved in 2 ml of a solution of 10 mM Tris-Cl, pH 7.5, 1mM EDTA and 0.5%
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SDS.  The solution was vortexed with 2 ml chloroform and centrifuged once more
for 10 minutes at 3000 x g.  Finally, the upper aqueous phase was precipitated with
the addition of 6 ml absolute ethanol in the presence of 0.3 M Na acetate, pH 6.0.
To the pellet after a final centrifugation step of 10 minutes at 3000 x g, RNA was
dissolved in an appropriate volume of TE.
4.1.6 Isolation of mRNA
A Pasteur pipette was baked and silanised, and siliconised glass wool was added
to the narrow end to act as a filter.  1 ml of a 25 mg/ml suspension of oligo-dT
cellulose (Stratagene, USA) was added to the pipette and washed with 20 ml of
binding buffer.   1 mg of total RNA was heated for 5 minutes at 70°C in mRNA
binding buffer, and applied to the column.  The flowthrough was collected and
added once again to the column, until the sample had run through the pipette four
times to allow for sufficient binding, and the column was then washed repeatedly
with binding buffer to remove unbound RNA.  Elution was with 1.6 ml mRNA
elution buffer.  The mRNA was precipitated by the addition of 160 µl 3 M NaOAc
pH 6.0 in a silanised Corex tube, and the pellet was resuspended in ddH2O to an
approximate concentration of 1 mg/ml.
4.1.7 Synthesis of cDNA from mRNA
The synthesis of both cDNA strands in the production of cDNA libraries was
achieved by the use of Avian Myeloblastosis Virus (AMV) Reverse Transcriptase.
Two micrograms of template was added to a reaction buffer containing 50 mM
Tris-Cl pH 8.3, 8 mM MgCl2, 1 mM DTT, 30 mM KCl 10 mM dNTPs and 3 µG
random primer p(dN)6 (Roche, Mannheim, Germany) supplemented with 50 U of
AMV Reverse Transcriptase. The reaction was allowed to continue for 1 hour at
37°C.
4.1.8 Polymerase chain reaction (PCR)
4.1.8.1 Amplification of RNA and DNA fragments by PCR
The basic reaction comprised 30 cycles, the first of which was preceded by an
initial 3 minute denaturation step at 94°C during which time Taq polymerase was
added to the reaction mixture.  Each cycle consisted of a denaturation step at 94°C
for 1 minute, an annealing step for 1 minute at a temperature derived individually
from the expected melting temperature of the oligonucleotides used (see below)
and an elongation step for 1 minute at 72°C. The program ended with a final
extension step at 72°C for 5 minutes.
PCR was carried out in a final volume of 50 µl containing 10 ng linearised
template, 0.2 mM dNTPs, 1 mM MgCl2, 10 pmoles ‘forward’ primer, 10 pmoles
‘reverse’ primer, 1x polymerase buffer (20 mM Tris-Cl pH 8.0, 0.1 mM KCl 20 mM
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DTT, 0.1 mM EDTA, 0.5% Nonidet P40 (v/v), 0.5% Tween 20 (v/v)) and 0.5 U
Polymerase, Erlich (1991)56.
4.1.8.2 Calculation of primer annealing temperature
The annealing temperature of the reaction was calculated as:
T = Tml-5
Where Tml was the Tm of the oligonucleotide with the lowest melting temperature as
calculated below.
The melting temperature of every oligonucleotide primer was established
according to the equation:
Tm   = 2((A+T)+2(G+C))
(Where A, C, G, and T correspond to the number of each respective
deoxyribonuclotides in the oligonucleotide.)
The equation neglects the effect of salt but was taken as a useful approximation of
optimal Tm .
4.1.9 Site-directed mutagenesis of DNA
In Vitro Mutagenesis of DNA was performed according to Messing (1983) and
Kunkel (1985) as follows:
4.1.9.1 Production of uracil-containing single stranded M13 DNA
5 ml LB medium were inoculated with 100 µl CJ236 overnight culture and
incubated at 37°C with agitation until early log phase.  This culture was then
infected with 108 M13 plaque-forming units.  The culture was incubated overnight
at 37°C with agitation.  1.2 ml of culture was then transferred to a microfuge tube
and centrifuged for one minute.  The supernatant was transferred to a second
microfuge tube, centrifuged and again transferred to a fresh tube.  The phage
particles were precipitated from the lysate by incubation at room temperature for
20 minutes after the addition of 300 µl 20% PEG/NaCl.  The mixture was
microfuged at full speed and the supernatant discarded.  The phage sediment was
resuspended in 300 µl TE10/1 buffer protein was removed by the addition of 200 µl
of water-saturated phenol/chloroform.  The mixture was vortexed strenuously and
centrifuged at full speed in a microfuge for one minute.  The upper, aqueous phase
containing the single-stranded DNA was retrieved and precipitated by the addition
of 200 µl 7.5 M NH4Ac (pH 7.5) and 800 µl absolute ethanol, incubating at –70°C
for 10 minutes then microcentrifuging at full power for 20 minutes. The pellet was
washed in 70% ethanol to remove salt, allowed to air dry and resuspended in 20 µl
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H2O.  The quality of the single-stranded DNA was analysed by visualisation on a
1% agarose gel.
4.1.9.2 Site-directed mutagenesis
Hybridisation of phosphorylated oligonucleotide was effected using the following
procedure:  200 ng of single-stranded DNA and 2-3 pmol of phosphorylated
oligonucleotide in hybridisation buffer (2 mM Tris-Cl pH 7.4, 0.2mM MgCl2, 5 mM
NaCl) in a total volume of 10 µl were incubated at 70°C for 2 minutes, then allowed
to cool to room temperature.  The mixture was transferred to ice and the following
components were added: 1 µl 10 x Synthesis buffer ( 5mM dNTP mix, 100 mM
Tris-Cl pH 7.5, 50 mM MgCl2, 20 mM DTT), 5 E T4-DNA Ligase (1µl), 1 µg T4-Gen
32 Protein (0.5µl) and 3 E T4-DNA polymerase.  The reaction mixture was
incubated for 5 minutes on ice, then for 5 minutes at 25°C and finally for 90
minutes at 37°C after which time the reaction was stopped by the addition of 80 µl
of TE 10/1.  10 µl was used to transform competent E.coli bacteria.
4.1.10 DNA gel electrophoresis
The separation of DNA fragments, that were all between 250 bp and 14 kB was
achieved using agarose gel electrophoresis, Sambrook (1989) 48. Unless otherwise
stated 1.2% agarose was used for all preparative and analytical gels.  The DNA to
be separated was administered in 1x DNA-loading buffer.  The gel was visualized
after staining with ethidium bromide using a UV365nm light source.
4.1.11 Extraction of nucleic acids from agarose
Following restriction, DNA was electrophoresed in an agarose gel. Agarose
containing a restriction fragment of interest was excised and weighed. Three
volumes of solubilisation buffer (QIAEX II Gel extraction kit, QIAGEN) were added
together with 10 µl of silica particles. The sample was vortexed and incubated at
50°C for 10 min. The sample was then centrifuged and the pellet washed with 500
µl of solubilisation buffer. After subsequent centrifugation the pellet was washed
twice with 500 µl of a high salt-ethanol wash buffer and air-dried for 2 min. Elution
of DNA from the silica beads was carried out by adding 20 µl of 10 mM Tris-Cl, pH
8.5 and incubating for 5 minutes at 50°C. Centrifugation ensured that the eluate
was free of silica for subsequent manipulations.
4.1.12 Purification of PCR products
PCR products were electrophoresed in an agarose gel and the product was
excised and purified using the QIAEX II Gel Extraction Kit according to the
manufacturers recommendations.
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4.1.13 Desalting and concentration of nucleic acids
Where more than one step was required to successfully modify DNA, it was often
necessary to change the buffer conditions, especially where downstream
enzymatic reactions were sensitive to residual salt. This was achieved by
precipitation in absolute ethanol followed by a wash step with 70% ethanol and air-
drying. The same method was also used to concentrate DNA samples.
4.1.14 Cloning of DNA
4.1.14.1 Ligation of DNA fragments
 DNA ligation was performed according to the method published by King &
Blakesley (1986) 57.
4.1.14.2 Preparation of competent E.coli
Preparation of competent cells was according to Inoue et al. (1990)58
4.1.14.3 Transformation of plasmid DNA into competent E.coli
50 µl of suspension of competent E.coli prepared using the above protocol was
added to 10 ng of supercoiled plasmid (prepared by the alkaline lysis procedure) or
5 µl of ligation reaction.  The mixture was incubated on ice for 20 minutes, rapidly
transferred to a water bath preheated to 42°C for 50 seconds and immediately
placed back on ice for 2 minutes.  1 ml LB medium was added, and the mixture
was incubated at 37°C for one hour.  After this time, 200 µl of culture was spread
onto agar plates made with LB containing ampicillin (100 µg/ml).  The remainder of
the culture was centrifuged at low speed and the pellet resuspended in 50 µl LB.
This was then spread on a second LB amp plate.  The plates were incubated for
14 hours at 37°C after which time individual colonies were visible that could be
collected and transferred to 4 ml LB for incubation overnight at 37°C.
4.1.15 DNA sequencing
DNA sequencing followed the method originally described by Sanger et al (1977)
59.
4.2 Protein chemistry and biochemistry
4.2.1 Preparation of mammalian cell lysates for analysis
To analyse specific cellular proteins using the techniques of protein chemistry, cell
lysates were prepared with buffer containing Triton X-100.  Treatment with this mild
non-ionic detergent has the effect of solublising the plasma membrane, whilst
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leaving cytoskeletal proteins insoluble and the cell nucleus intact.  Enabling the
separation of other cellular proteins from these components.  Before lysis, the cells
were washed twice with ice-cold PBS and an appropriate volume of Triton X-100
lysis buffer was added relative to the area of the dish (a 10 cm cell culture petridish
was treated with 1 ml buffer).  After 5 minutes incubation on ice, the lysates was
scraped to the bottom of the dish and transferred to a microfuge tube.  The tube
was centrifuged at full speed and the supernatant was transferred to a new tube.
Cell lysates were used immediately or stored at –70°C.
4.2.2 Electrophoretic separation of proteins by Laemmli SDS-
PAGE
One-dimensional denaturing gel electrophoresis was performed as described by
Laemmli (1970) 60. Proteins were solublised by boiling in the presence of Laemmli-
buffer (2 x). An aliquot of the sample was applied to a 12% acrylamide gel and
electrophoresis was performed at room temperature at a constant current of
approximately 1mA/cm. The gel front was allowed to migrate out of the gel before
electrophoresis was discontinued. Commercially available protein standards
(Sigma, Munich, Germany) enabled the estimation of apparent molecular weight.
4.2.3 Staining proteins in gels
Proteins were stained after electrophoresis by Coomassie Blue staining according
to Sambrook (1989)48.
4.2.4 Protein blotting
Protein transfer from an SDS gel to or Hybond-ECL nitro-cellulose membrane was
carried out by electroblotting in a semidry electroblotter according to Ausubel
(1995) 61. Immediately after gel electrophoresis a blot-sandwich was assembled
and the proteins transferred at room temperature at a constant current of 0.8
mA/cm2 for 3-5 hours. The transfer was subsequently interrupted, the blot-
sandwich disassembled and the blot stained in Ponceau S solution, allowing
protein molecular weight indicators and bands of interest to be marked and transfer
efficiency to be estimated. Complete destaining with NET/gelatine was necessary
before the blot could be incubated with specific antibodies.
4.2.5 Immunodetection (Western blotting)
The procedure was carried out according to the procedure described by Harlow &
Lane (1988)62.  Briefly, the membrane was incubated with antibodies that
specifically recognised the target protein.  Polyclonal antibodies were used at a
dilution of 1:1000 in NET/gelatine. Before incubating the blot with antibody, the
membrane was immersed in NET/gelatine for one hour. Subsequently, the blot
was incubated in NET/gelatine containing the primary antibody and gently shaken
overnight at 4°C. The blot was washed again in NET/gelatine and incubated with
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enzyme-antibody conjugate at room temperature for one hour.  The membrane
was washed three times for 20 minutes at room temperature to remove excess
secondary antibody conjugate, and specific proteins were visualised by use of the
ECL kit (NEN), following the manufacturers instructions.
4.2.6 Immunoprecipitation
The lysate was spun at high speed, transferred to a fresh tube and incubated on
ice with 10 µl hybridoma tissue culture supernatant or 5 µl rabbit serum for 1 hour.
50 µl of protein G-bound sepharose beads was added and the lysate placed on a
rotating arm for 2 hours at 4°C. The beads were pelleted by centrifugation and
washed twice for 10 minutes in l ml of lysis buffer. Antigen was eluted by boiling
the beads in 20 µl of 2x Laemmli-buffer.
4.2.7 Immunolocalisation
Immunofluorescence allows for an examination of the subcellular localisation of
proteins.  Cells are first fixed, then permeabilised with a mild detergent to allow the
antibody access to subcellular compartments within the cell.  Unspecific binding
sites are blocked with PBG, and then the cells are immersed in a solution that
contains antibody recognising the desired protein (the primary antibody).   The
sample is washed a second time and incubated with a second antibody that
recognises the primary antibody (the secondary antibody).  This antibody is
coupled to a fluorophore.  The emitted light of the fluorophore betrays the
subcellular localisation of the target protein when examined by fluorescence
microscopy while exposing the sample to light at the excitation wavelength of the
fluorophore.
Adherent cell cultures were seeded on sterile, uncoated glass cover slips in a small
cell culture well.   At 50% confluency, the cells were washed with PBS and
incubated for 30 minutes at 4°Cwith 2% Paraformaldehyde in 0.1 M Sodium
cacodylate buffer, pH 7.4 (Electron Microscopy Sciences, USA).  After washing 3
times in 100 mM Glycine in PBS for 10 minutes each time, the cells were
immersed in 0.2% Tween 20 in 1xPBS to permeablise them and washed several
times in PBG, then incubated with the primary antibody for at least two hours at
RT.  The best dilutions for the primary and secondary antibodies were determined
empirically.  The cells were washed again several times in PBG to remove residual
unbound antibody and subsequently incubated with Cy3-konjugated secondary
antibody (Molecular Probes, Leiden, Netherlands) for 2 hrs at RT.  All stages
following application of the secondary antibody were performed in the dark.  Cells
were finally incubated with DAPI in PBS for 10 minutes at RT, the cells washed
once more and mounted upside down onto a glass slide in Permafluor (Molecular
Probes, Leiden, Netherlands).  Samples were visualised and photographed with a
Zeiss Axiovert X-100 Digital Confocal Microscope.
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4.3 Methods in cell biology
4.3.1 General cell culture techniques
All mammalian cells were cultivated in a humidified incubator (Heraeus, B5060
Ek/CO2) at between 5 and 7% CO2, 37°C.  All cell culture work was carried out
aseptically under a laminar flow hood (Heraeus, Laminair).  Cell were regularly fed
and passaged with fresh medium.  Cells were frozen on dry ice in freezing medium
(90% FCS, 10% DMSO).  Cells were counted with a Neubauer Counting Chamber
(Sigma, Munich, Germany).
4.3.2 Transfection of mammalian cells with plasmid DNA
Unless otherwise indicated, plasmid DNA was introduced to mammalian cells
using the calcium phosphate method 63.  Transfections carried out using
Lipofectamine(Gibco BRL, Eggenstein, Germany) adhered to the manufacturer’s
stipulations.  Where necessary, efficiency of transfection was assessed using a
parallel transfection with pCDNA3 GFP, the number of green cells showing up in
fluorescence microscopy giving a satisfactory estimate of the number of positive
transfectants.
4.3.3 Retroviral gene transfer into NIH3T3 cells
To produce stable NIH3T3-derived cell lines that overexpressed a particular
protein, BOSC 23 cells50 were seeded on a 10 cm cell culture dish and transiently
transfected with retroviral expression vector (pLXSN or pIRES) containing as an
insert the construct to be expressed.  24 hours after the transfection, the medium
was replaced with 5 ml of fresh medium and left overnight to collect secreted virus
particles after which time the medium was filtered through a 0.45 µm sterile filter.
For infection, exponentially growing target cells were seeded onto 6 cm cell culture
dishes and allowed to spread.  3 ml of collected and filtered BOSC medium was
administered to the cells in the presence of Polybrene at a concentration of 8
µg/ml.  The cells were incubated at 37°C for between 4 and 16 hours.  After
infection the medium was changed and cultured for two weeks in medium
containing G418 to obtain stable cell lines.  Individual G418-resistant colonies
resulting from the amplification of a single cell were isolated and cultured
separately to obtain monoclonal cell lines.  The expression of the target protein
was usually assessed by Western blot with specific antibodies.
4.3.4 In vitro src-family kinase assay
This assay is based on the protocol found in Ausubel (1995)61, with some
modifications.  Enolase was used as the exogenous substrate for the src-family
kinase assay.  It was however necessary to denature the enolase by acid
treatment for it to function as an appropriate substrate.  Preparation of the enolase
was as follows:
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100 µg of enolase suspension from rabbit muscle (Roche, Mannheim, Germany)
was microfuged at full speed at 4°C.  The supernatant was retained and 10 µl of a
solution of 1 mM DTT, 50 mM HEPES pH 7.0 was added, and incubated for 60
minutes on ice.  At this point, the enolase could be stored at –70°C for later use.
An equal volume of 100 mM acetic acid was added to the enolase and the mixture
was incubated for 5 minutes at 30°C, before replacing on ice.  This acid-denatured
enolase was used no later than one hour after preparation.
Immunoprecipitations were performed as described above, and after the last wash
was aspirated, 20 µl of src kinase assay buffer containing 5 µCi of [γ-32P] ATP and
1 µg of acid-denatured enolase was added to the beads.  The sample was
incubated for 10 minutes at 30°C after which 20 µl Laemmli sample buffer was
added.  The samples were separated by SDS PAGE and blotted to a nitrocellulose
membrane.  Western blots were carried out, if necessary at this stage, after which
time the membrane was exposed to autoradiography to identify [γ-32P] - labelled
proteins.
4.3.5 Cell adhesion assay
The cell adhesion assay was carried out according to the method described by
Lagenaur et al. (1987)64.  Briefly, 1 µg of each respective protein was immobilised
onto nitrocellulose-coated plastic dishes (35 mm) by air-drying at RT.  Unspecific
binding of cells to nitrocellulose was prevented by blocking with 1% BSA solution in
PBS.  A total of 3 x 105 haematopoietic cells in serum-free medium were allowed to
adhere to the immobilised protein for 1 hour at 37°C.  Non-adherent cells were
removed by gently rinsing the dishes with warm PBS.  Specific binding was
evaluated under a phase contrast microscope.
4.3.6 Photometric quantification of viable (living) cells by MTT
assay
To quantify viable adherent cells the method described by Mosmann (1993) 65was
used.  The test measures the activity of certain mitochondrial enzymes and
therefore reflects the total number of living cells.  The substrate, MTT (3-[4,5-
Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) is converted by these
enzymes into an insoluble violet compound, which is readily measurable
photometrically.
MTT was added into the medium of adherent cells in a 96-well dish to a final
concentration of 0.6 mg/ml, and the cells were incubated for 2 hours at 37°C.  The
subsequent addition of isopropanol to 60% v/v and HCl to 12 mM lysed the cells
and solublised the violet precipitate.  The sample was measured at 570 nm against
a reference of 690 nm.
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4.4 Preparation of special expression systems
4.4.1 Preparation of new cloning vectors
4.4.1.1 pIRES vector
The pIRES cloning vector was designed for the eukaryotic expression of two
constructs simultaneously by achieving bicistronic transcription via the usage of the
encephalomyocarditis virus (ECMV) internal ribosomal entry site (IRES) in a
retroviral vector with separate concomitant neor under the independent control of
the SV40 promoter.
The ECMV IRES was cut from pLEN by digestion with EcoR1 and Bcl1 and
subcloned into pBluescript (KS), which had been opened up by digestion with Eco
R1 and Bam H1.  Bcl 1 has a sticky end that is compatible with that of Bam H1 so
the ligation of the insert into pBluescript destroyed both the Bcl 1 and Bam H1 site.
This vector was opened by digestion with Eco R1, the ends were blunted
(technique is described elsewhere here) and the vector religated to destroy the
site.  The insert was then again cut out from the vector by digesting with Xho 1 and
Not 1 and subcloned into pLXSN EKS (produced by J.Ruhe, this department,
unpublished) to give pIRES.
4.4.1.2 Production of pIRES/SIRP β1+DAP12
SIRP β1 was amplified by PCR using the two oligonucleotides Beta 1 f and Beta r
stop and subcloned into pIRES at these sites.  Subsequently, DAP12 was
amplified from cDNA with the two oligonucleotides DAP12 f not1and DAP12 Flag r
BstX1  and cloned into the vector to give pIRES/SIRP β1+DAP12.
4.4.1.3 pSj26 (mod) vector
The pSj26 (mod) cloning vector was designed for the eukaryotic expression and
secretion of C-terminal GST fusion proteins and was derived from the pCDNA3
cloning vector (Invitrogen) by the following procedure:
The complete DNA sequence coding for Schistosoma japonicum  Glutathione-S-
Transferase (GST) was amplified from the vector pGEX 2TK (Pharmacia Biotech,
Freiburg, Germany) by polymerase chain reaction (PCR) using the
oligonucleotides Sj26 (mod) f and Sj26 rev as primers. The PCR product was
digested with Xho 1 and Apa 1 and cloned into pCDNA3 at these sites.
4.4.1.4 Production of pCDNA3 IgGFc vector
The pCDNA3 IgGFc cloning vector was designed for the eukaryotic expression
and secretion of C-terminal Ig fusion proteins and was derived from the pCDNA3
cloning vector (Invitrogen) by the following procedure:
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The complete DNA sequence coding for the CH2 and CH3 regions of the human
IgG1 heavy chain was amplified from the vector pBSSK-CH2CH3 53 by polymerase
chain reaction (PCR) using the oligonucleotides h IgG1 f and h IgG1 r as primers.
The PCR product was digested with Xho 1 and Apa 1 and cloned into pCDNA3 at
these sites.
4.4.1.5 pSj26 (mod) or pCDNA3 IgGFc derived expression constructs
The coding region corresponding to the extracellular domain of SIRP α1,SIRP α2
or SIRP β1 was amplified from clones previously obtained1 by PCR using the
following primers:
Extracellular domain Oligonucleotides used
SIRP α1 ex and SIRP α2 ex: SIRP α f and SIRP α1ex rev
SIRP β1 ex: Beta 1 f and Beta ex r
The product obtained was digested with Eco R1 and Xho 1 and cloned into either
pSj26 (mod) or pCDNA3 IgGFc at these sites.
This method produced the following plasmids:
pSj26 (mod)/SIRP α1 ex
pSj26 (mod)/SIRP α2 ex
pSj26 (mod)/SIRP β1 ex
pCDNA3 IgGFc/SIRP α1 ex
pCDNA3 IgGFc/SIRP α2 ex
pCDNA3 IgGFc/SIRP β1 ex
4.4.2 Production and purification of secreted fusion proteins
The pSj26 (mod)-SIRPex or pCDNA3 IgGFc-SIRPex expression constructs were
transfected into 293 cells by the Calcium Phosphate method 63.  Cells were grown
in Dulbecco's Modified Eagle Medium supplemented with 10% FCS.  After
selection with 1 mg/ml G418 (Sigma) for 2 weeks, 10 surviving clones were tested
for expression and secretion of the protein by Western blot with antibody against
the extracellular domain of SIRP α that recognises both SIRP α and SIRP β 1.  A
single high-expressing clone was chosen and used to produce the fusion protein.
Medium was collected from confluent cultures daily. One litre of collected medium
was sterile filtered and incubated with mild agitation overnight at 4˚C with either 1
ml Glutathione sepharose (Pharmacia, Freiburg, Germany) for GST fusion
proteins, or 1 ml Protein A sepharose for h IgG fusion proteins.  The sepharose
was separated and washed with Phosphate-Buffered Saline (PBS).
For GST fusion proteins, elution was with 5 ml 10mM Glutathione for 10 minutes at
20°C.
For hIgG fusion proteins, elution was with 10 ml 100 mM Sodium citrate pH 2.2 into
a solution of 1 ml 1 M Tris-Cl pH 8 to immediately neutralise the pH conditions.
Both eluents were dialysed overnight 1:105 in PBS/10% glycerol.
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Protein concentration was determined using MicroBCA protein determination kit
(Pierce, Rockford, IL).
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5 Results
5.1 Extracellular domain of SIRP α1
5.1.1 Secretion of SIRP extracellular domains as GST fusions
The extracellular domain of SIRP α molecules comprises more than half of the
entire molecule, is highly glycosylated and contains three (or one) immunoglobulin-
like domains.  It is therefore reasonable to assume that the extracellular domain of
SIRP α molecules is likely to be involved in interactions with other molecules that
may be ligands.  In order to study this, a system was developed to produce and
isolate mature, eukaryotically processed extracellular domains as fusion proteins
with GST or hIgG1 fused to the C-terminal of the extracellular domain.  Using this
system, fusion proteins were derived from the extracellular domains of human
SIRP α1, SIRP α2, which are two members of the SIRP α family subtype, as well
as from the extracellular domain of SIRP β1, which is one member of the SIRP β
subtype.  These fusion proteins are denoted SIRP α1exGST, SIRP α2exGST,
SIRP β1exGST and SIRP α1exIgG, SIRP α2exIgG, SIRP β1exIgG, respectively.
The proteins were purified in sufficient abundance for use as antigens in antibody
production and in adhesion assays.  These proteins are depicted in Figure 4.
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Figure 4 Affinity purified GST- and IgG- extracellular domain fusion proteins from the
SIRP family.  1 µg of each purified fusion protein was separated on 10% SDS-PAGE and the gel
stained with Coomassie Blue.
Figure 4 shows that the proteins were all highly pure, and that despite their high
degree of similarity, SIRP α1 ex, SIRP α2 ex and SIRP β1 ex all had unique
mobilities on SDS PAGE. The additional cleavage site introduced between the
extracellular domain moiety and the GST tag was tested using enzymatic digestion
with commercially purified enterokinase as shown in Figure 5.  Although it was not
necessary for the ensuing experiments, the experiment is presented as a reference
for others wishing to use this secretion system.
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Figure 5 Cleavage of SIRP α1exGST with enterokinase.  1 µg SIRP α1exGST was digested for
20 hours at 37°C with increasing quantities of enterokinase (Roche, Mannheim).  Samples were
separated on 10% SDS-PAGE and bands were visualised by Coomassie Blue Staining.
Figure 5 presents an experiment to first test the sensitivity of the internal
enterokinase cleavage site to cleavage with enterokinase.  SIRP α1 extracellular
domain liberated from the GST tag (SIRP α ex) and the GST moiety itself (GST)
increase in a dose-dependent fashion while SIRP α1exGST is consequently
depleted.  As little as 0.15  µg are enough to produce significant cleavage of the
protein, however, some latent cleavage is visible even without addition of
enterokinase, possibly by cleavage by other proteases present in the extract.
Complete cleavage of SIRP α1exGST is not achieved, even when as much as
1.5µg of enzyme is used.  Unspecific protein degradation can also be seen at this
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dosage, which is not therefore appropriate.  Optimal cleavage therefore probably
occurs when 0.15-0.3 µg of enzyme is used.
5.1.2 SIRP ex GST fusions as antigens for immunisation
The GST fusion protein secretion system described above is able to produce pure
protein in milligram amounts, sufficient quantity for use as antigen in antibody
production.  Polyclonal antibodies against SIRP α1exGST and SIRP β1exGST
were produced and affinity-purified using the respective antigen as a ligand.
These antibodies are both sensitive and selective for their relevant antigens when
compared in Western blots of crude lysates prepared from HEK293 cells that
overexpress either SIRP α1 or SIRP β1 (Figure 6), although the murine
homologues of SIRP α and SIRP β are not detectable (results not shown).  These
antisera are therefore used throughout this study except where otherwise
indicated.
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Figure 6  Comparison of the selectivity of anti-SIRP α and anti-SIRP β antisera in Western
blot.  Lysates prepared from HEK293 cells transiently overexpressing SIRP α1 (both pictures, lanes
3 and 4) or SIRP β1 (both pictures, lanes 5 and 6) were separated on SDS-PAGE and subjected to
Western blot with affinity purified α-SIRP α (A) or α-SIRP β (B) antiserum.
5.1.3 Cell adhesion to SIRP ex GST fusions
In order to investigate the potential affinity of the extracellular domain of different
SIRPs for cell surface molecules, the purified proteins were immobilised on cell
culture dishes and cells of different type and lineage were dispersed over the plate
and allowed to settle. The plates were washed and photographed and the degree
of adhesion was approximated by eye.  Eleven different cell types were examined
in this way, and two typical adhesion profiles are presented in Figure 7. Results of
all cell lines are tabulated in Figure 8.
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Figure 7  Adhesion profiles of two human cell lines (MCF10A and MEG-01) to an array of GST
or IgG fusion proteins.  Cells were dispersed over proteins spotted onto cell culture plates and
allowed to settle.  After gentle washing, the plates were photographed.  The protein immobilised on
the plate is labelled under each photograph.
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Figure 8  Comparison of eleven cell lines in adhesion assay.  Adhesion assay was performed
as described.  Photographs were judged by eye and assigned marks representative of their relative
adhesion, ranging from “–” (no adhesion) to “+++” (strong adhesion).
The following observations can be made from the table in Figure 8:  Firstly, there is
virtually no adhesion to GST alone, meaning that when cells adhere, it is to the
SIRP extracellular domains. Secondly, all cell lines tested are able to adhere to
both SIRP α1exGST and SIRP α2exGST, to different degrees.  While cell
adhesion varies with the cell line used, results with SIRP α1exGST are the same
as with SIRP α2exGST.  However, only one cell line, MCF10A, adheres to
SIRP β1exGST.
There is a significant difference in cell adhesion pattern between the GST fusion
proteins and their IgG fusion proteins.  In seven out of the eleven cell lines tested,
adhesion to SIRP α1exIgG and SIRP α2exIgG was the same as SIRP α1exGST
and SIRP α2exGST.  In four cases, however, there was no adhesion to the
SIRP α1exIgG and SIRP α2exIgG while there was substantial adhesion to
SIRP α1exGST and SIRP α2exGST.
5.1.4 CD47 (IAP) is an extracellular ligand for SIRP α
The previous result was taken to mean that many different cell types express a
ligand for SIRP α molecules.  A project was undertaken in collaboration with Drs.
H.-J. Bühring and M. Seiffert to find a ligand for SIRP α1.  In order to identify
Cell line Description
BSA
Poly-L-Lysine
Fibronectin
G
ST
SIRP α1ExG
ST 
SIRP α2ExG
ST 
SIRP β1ExG
ST 
SIRP α1ExIgG
 
SIRP α2ExIgG
SIRP β1ExIgG
 
MCF7 Breast Carcinoma - +++ ++ - +++ +++ - ++ ++ -
U937 Histiocytic Carcinoma - - - - +++ +++ - +++ +++ -
K562 Myelocytic Carcinoma - - - - +++ +++ - +++ +++ -
Jurkat Acute T-cell Leukaemia - - - - ++ ++ - +++ +++ -
MCF10A Human Mammary Gland - +++ +++ - +++ +++ +++ - - -
KG1 Acute Myelogenous Leukaemia - - - - +++ +++ - - - -
Raji Burkitt's Lymphoma - + - - +++ +++ - +++ +++ -
NT2 Testicular Teratocarcinoma -/+ +++ +++ -/+ +++ +++ - +++ +++ -
MEG01 Megakaryoblastic Leukaemia - ++ - - ++ ++ - +++ +++ -
Human melanocytes - ++ ++ - +++ +++ - - - -
COS7 Transformed Monkey Kidney Cells - - ++ - +++ +++ - - - -
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potential ligands for SIRP α molecules, SIRP α1exGST was biotinylated and
incubated with cells.  Using flow cytometry, a cell line was selected for particularly
high affinity for the fusion protein and therefore with a high expression level of
“SIRP α-ligand”.  A single cell type was selected and a panel of mAb was screened
to isolate an antibody that could compete with the association.  One such antibody
was found, “CC2C6”, that recognised CD4721.
To confirm the association of CD47 with SIRP α1, two cell lines were used for
comparison: the ovarian carcinoma cell line OV10 expresses no detectable CD47
using experimental assays, including Western blot, Northern blot and RT-PCR66.
Stable control (OV10/X) and CD47-expressing (OV10/CD47) cell lines, derived
from the OV10 ovarian carcinoma cell line, were obtained and screened in the
adhesion array in the manner described previously.  The results of this experiment
are presented in Figure 9.
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Figure 9  CD47 is a ligand for SIRP α.  The picture shows a comparison of OV10 cells (OV10/X)
not expressing CD47 with OV10 cells overexpressing CD47(OV10/CD47) in adhesion assay.  The
immobilised probe protein is labelled beneath its respective photograph.
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Figure 9 shows that cells overexpressing CD47 (panel B) adhere strongly to both
SIRP α1exGST and SIRP α1exIgG (plates 2 and 5).  However, cells that do not
express CD47 (panel A) are unable to adhere to SIRP α1exIgG (plate 2), but still
adhere to SIRP α1exGST (plate 5).   Neither control cells nor cells overexpressing
CD47 adhere to SIRP β1exGST or SIRP β1exIgG (both panels, plates 3 and 6).
5.2 Regulation of SIRP α1 phosphorylation by tyrosine
kinases
SIRP α is tyrosine phosphorylated following numerous different stimuli.  It has
been postulated that RTKs are directly responsible for SIRP α tyrosine
phosphorylation1.  Others have suggested that src family kinases are responsible
for this tyrosine phosphorylation39.  A431 cells, which express SIRP α and EGFR in
abundance, were used as a model system to identify whether the kinase that
directly phosphorylates SIRP α following EGF stimulation is either the EGFR or a
cytosolic (src-family) tyrosine kinase.  A431s cells were stimulated with EGF either
with or without preincubation with PP1, a selective src-family kinase inhibitor.
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Figure 10  Treatment with the src-family kinase inhibitor PP1 inhibits EGF-induced tyrosine
phosphorylation of SIRP α. A431 epithelial carcinoma cells were stimulated with 20 ng/ml EGF for
5 minutes (lanes 2 and 4) and 10 µM PP1 for 15 minutes.  Cell lysates were immunoprecipitated with
ExC2 anti-SIRP α polyclonal antiserum, homemade anti-SHC antiserum or anti-EGFR mAb 108.
Immunocomplexes were separated on 10% SDS-PAGE and tyrosine phosphorylated proteins were
detected in Western blot with anti-phosphotyrosine antibodies.
The results shown in Figure 10 show that EGF stimulation leads to the tyrosine
phosphorylation of SIRP α  (panel A, compare lanes 1 and 2).  However, treatment
with PP1 abolishes this induced tyrosine phosphorylation.  The selectivity of the
inhibitor for the kinase that tyrosine phosphorylates SIRP α is illustrated in panel B,
where the SHC adaptor protein, an established substrate of the EGFR, was
immunoprecipitated and detected in Western blot with an anti-phosphotyrosine
antibody (compare lanes 1 and 2 with lanes 3 and 4).  The induced tyrosine
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phosphorylation of SHC is largely unaffected by PP1 treatment, bearing witness to
the selectivity of the inhibitor for a different kinase.  This experiment suggests that
another tyrosine kinase mediates the tyrosine phosphorylation of SIRP α, and that
this may be a src-family cytosolic tyrosine kinase. Identical results to those shown
in Figure 10 were obtained when PDGF-, FGF-, or insulin stimulation was
employed in place of EGF stimulation (results not shown).
Although often effective, most inhibitors do not show an absolute specificity for
their targets, so further experiments were necessary to test whether or not
EGF-induced SIRP α tyrosine phosphorylation was src-family kinase dependent.
COS-7 transformed kidney epithelial cells were chosen because they can be
effectively transfected.  Stable polyclonal cell lines were produced that
overexpressed human SIRP α1, which were transiently super-transfected with
constructs that overexpressed kinase-inactive forms of different tyrosine kinases.
Figure 11 shows the result of this experiment.
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Figure 11  Constitutive tyrosine phosphorylation of SIRP α by overexpression of kinase-
inactive mutants of different src-family tyrosine kinases.  COS7/SIRP α1 cells transiently
transfected with pCDNA3 constructs overexpressing either a kinase inactive form of c-src
(pCDNA3/c-src K/R) or c-fyn (pCDNA3/c-fyn K/R).  Cells were stimulated with 20 ng/ml EGF for 5
minutes.  Cell lysates were immunoprecipitated with ExC2 anti-SIRP α polyclonal antiserum and
immunocomplexes were separated on 10% SDS-PAGE.  Tyrosine phosphorylated proteins were
detected in Western blot with anti-phosphotyrosine antibodies (upper panel) or ExC2 antibodies
(lower panel).
Neither a kinase-inactive c-src or kinase inactive c-fyn were able to inhibit EGF-
induced tyrosine phosphorylation of SIRP α1.  Indeed, overexpression of either
kinase inactive molecule enhanced the basal tyrosine phosphorylation of SIRP α.
This probably means that the kinase activity of these src-family members is not
essential for the tyrosine phosphorylation of SIRP α.  The enhanced basal tyrosine
phosphorylation of SIRP α may therefore be due to a second function of the src-
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family tyrosine kinases, e.g. an adaptor role.  If the src-family member is able to
recruit further kinases to the SIRP α complex through other domains or motifs, it
may be indirectly responsible for the effect seen in the experiment.
This all suggests that the sequence of events leading to the tyrosine
phosphorylation is a complex program, involving further molecules and possibly
another order of tyrosine kinase activity.  SIRP α1 indeed associates with
molecules that have tyrosine kinase activity in a manner both dependently and
independently of its own state of tyrosine phosphorylation (Figure 18, later).
5.3 Association of SIRP β1 with DAP12
5.3.1  SIRP β, DAP12 and Syk form a physical complex in
HEK293 cells
To address the relevance of SIRP β as a signal transduction molecule, it was
necessary to rationalise a manner by which it would be able to transmit an
intracellular signal.  SIRP β molecules have no intracellular domain themselves;
therefore a logical rationale would be to deduce potential molecules with
intracellular domains that might associate with either the extracellular and/or
transmembrane domain of SIRP β.  KIR2DS2, a member of the Killer Inhibitory
Receptor Family (KIR), has been shown to associate non-covalently with a
transmembrane adaptor protein (DAP12) involving an ionic interaction between
two amino acids of opposing charge within their adjacent transmembrane domains
(Figure 12).
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Figure 12  Association of KIR2DS2 with DAP12 (after Colonna, Nature 391, 1998 67)
Although distinct in terms of primary amino acid sequence from known SIRP family
members, KIR2DS2 shares certain structural characteristics with SIRP β.  Both are
transmembrane glycoproteins with large extracellular and no intracellular domains,
and both have a single positively charged amino acid (a lysine K) within the
transmembrane of the molecule.  It was therefore reasonable to suggest that
SIRP β1 might associate with DAP12.  To test this hypothesis, HEK293 cells were
cotransfected with pCDNA3 overexpressing SIRP β1 and a Flag-tagged DAP12
The result is presented in Figure 13(A).
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Figure 13(A) Western blots of SIRP β immunoprecipitates from HEK293 cells.  Cells have
been transiently transfected with pCDNA3 overexpressing either DAP12 (‘Flag’-tagged, lanes
2,4,6,8) or SIRP β  (lanes 3,4,7,8).  Cells were stimulated with 1mM sodium pervanadate for 10
minutes (PoV, lanes 5-8), before lysis.  Immunocomplexes were separated by 8%-16% SDS-PAGE.
Proteins were detected in Western blot using anti-phosphotyrosine, α-SIRP β or α-Flag antibodies.
Figure 13(A) shows that DAP12 is part of an immunocomplex immunoprecipitated
by anti-SIRP β independently of DAP12 tyrosine phosphorylation and is therefore a
constitutive association (lower picture, lanes 4 and 8).  Accordingly, SIRP β1 is
detectable in the immunocomplex immunoprecipitated by anti-Flag antibodies.
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Remarkably, a tyrosine-phosphorylated band of 74 kDa is part of the
immunocomplex (upper picture, lane 8) following treatment with 1mM sodium
pervanadate (PoV).  This molecule is identified as the cytosolic tyrosine kinase Syk
in the experiment shown in Figure 14.  The two bands labelled in Figure 13(A) as
SIRP α are probably tyrosine phosphorylated endogenous SIRP α cross-reacting
with the anti-SIRP β antibodies.  The SIRP α bands are not part of the
immunocomplex because they do not precipitate with anti-Flag antibodies and are
competed by overexpression of SIRP β1 (compare lanes 5&6 with Lanes 7&8).
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Figure 13(B) Western blots of DAP12 (Flag) immunoprecipitates from HEK293 cells.  Cells
have been transiently transfected with pCDNA3 overexpressing either DAP12 (‘Flag’-tagged, lanes
2,4,6,8) or SIRP β  (lanes 3,4,7,8).  Cells were stimulated with 1mM sodium pervanadate for 10
minutes (PoV, lanes 5-8), before lysis.  Immunocomplexes were separated by 8%-16% SDS-PAGE.
Proteins were detected in Western blot using anti-phosphotyrosine, α-SIRP β or α-Flag antibodies.
The upper picture in Figure 13(B) shows that pp74 (Syk) associates with anti-Flag
immunoprecipitates and overexpression of SIRP β1 neither interferes with, nor
promotes this association.  It is assumed therefore that Syk associates with
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SIRP β through DAP12 and not vice versa, and that the associations utilise
independent binding sites on DAP12.
Figure 14  Identification of pp74 as Syk.  Comparison of parental HEK293 cells with four selected
clones from a panel of stable G418-selected monoclonal cell lines produced from HEK293 cells
transfected with pSj26/DAP12.  Cells were treated with 1mM sodium pervanadate (PoV) for 10
minutes and GST-DAP12 was precipitated from the cell lysates with GSH sepharose.  Complexes
were separated on 8% - 16% SDS PAGE and bands were visualised in Western blot with anti-Syk
polyclonal antiserum, or anti GST polyclonal antiserum as control.
The experiment presented in Figure 14 identifies pp74, the kinase that directly
associates with DAP12 as Syk.
5.3.2 Syk expression in non-haematopoietic cells
Since Syk is thought to be a tyrosine kinase restricted to haematopoietic cell
lineages, it is necessary to confirm the presence of endogenous Syk in HEK293
cells.  PCR amplification of Syk from cDNA prepared from HEK293 cells confirms
this using primers specific for the coding region of human Syk. (Figure 15, lanes 1-
3).
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Figure 15  Amplification of Syk from HEK293 and NIH3T3.  PCR from cDNA prepared from
HEK293 and NIH3T3 cells using PCR primers specific for human (lanes 1-3) and murine (lanes 4-6)
Syk, respectively.  Lanes 1,3-4,6 with no template cDNA as control, Lane 2 contains HEK293 cDNA,
Lane 5 contains NIH3T3 cDNA.  30 cycles of PCR were performed.
The result in Figure 15 shows a single band of the expected size amplified from
HEK293 confirming the endogenous expression of Syk in these cells and outside
the haematopoietically-derived lineages.  The analogous experiment is presented
to show expression of murine Syk in NIH3T3 cells (4-6) which then provides an
ideal model adherent cell line for the further biological experiments that are
presented later.
The previous experiments support the existence of a potential multiprotein complex
composed of SIRP β, DAP12 and Syk.  The in vitro kinase assay presented in
Figure 16 provides further evidence of a link between this complex and proteins
that may be involved in downstream signal transduction pathways.
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Figure 16  Evidence of a multiprotein complex clustered around GST-DAP12 in activated
HEK293 cells.  Parental HEK293 cells (lanes 1-2) and HEK293/GST-DAP12 clone 4 (lanes 3-4),
were obtained as outlined in Figure 14.  Cells were treated with 1mM sodium pervanadate (PoV) for
10 minutes (lanes 2 and 4) and GST-DAP12 was precipitated from the cell lysates with GSH
sepharose.  An in vitro kinase assay was performed on the complexes.  No exogenous substrate
was added.  The complexes were separated on 8% -16% SDS PAGE and bands were visualised by
autoradiography.
The in vitro kinase assay presented in Figure 16 reveals a number of
phosphorylated bands associated in a complex coprecipitating with GST-DAP12,
one of these (at ~72 kDa) is probably Syk.  Two other outstanding bands of 38-
and 30 kDa are also visible.  It is possible that p38 could be the MAP kinase of the
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same name, since its association with Syk in haematopoietic lines has already
been reported.  The 56 kDa band may correspond to a src-family tyrosine kinase,
since these are required for full activation of Syk in the context of the B-cell
receptor.  Although none of these bands other than Syk were strong enough to be
detected with specific antibodies in Western blot, this experiment strongly suggests
the formation of a multiprotein tyrosine phosphorylated signal transduction complex
assembling around DAP12 in activated cells.
5.3.3 SIRP β/DAP12 complex inhibition by SIRP α coexpression
SIRP α is an ITIM motif-containing protein, and the negative influence of ITIM-
containing inhibitory receptors upon the ITAM-containing activating receptors is
increasingly often observed in immunology2.
Since DAP12 is an ITAM-containing receptor, the potential of overexpressed
SIRP α1 to influence the signalling through SIRP β/DAP12 was investigated.  The
first experiment (Figure 17) suggests that SIRP α1 overexpression can inhibit the
kinase activity of Syk.  At the same time, Syk becomes tyrosine phosphorylated,
suggesting that this inhibition may involve a tyrosine kinase activity.
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Figure 17  Inhibitory influence of SIRP α on DAP12 signalling.  HEK293 cells were transfected
with pCDNA3/DAP12 (lanes 7,8,11,12) along with pCDNA3/SIRP α1 (lanes 3-4,9-10,13-14) and
pCDNA3/SIRP β1 (lanes 5-6, 11-14).  Cells were stimulated with 1mM sodium pervanadate (PoV)
as indicated.  DAP12 was immunoprecipitated from the cell lysates and an in vitro kinase assay was
performed using enolase from rabbit muscle as exogenous substrate.  Proteins were separated on
12% SDS-PAGE and tyrosine phosphorylated proteins were detected in Western blot (upper panel).
Proteins that had been phosphorylated during the kinase assay were detected by autoradiography
(lower panel).
Figure 17 shows that DAP12 coprecipitates with a kinase activity that is able to
phosphorylate enolase as well as two other proteins.  Enolase is a popular
substrate used in in vitro kinase assays to detect src family kinase activity.  One of
these phosphorylated proteins is the exact same size as Syk while the other
approximately 55 kDa protein is unknown.  It may correspond to CSK, a 55kDa
SH-2 domain-containing protein that has been shown to associate in vitro with
SIRP α20.  A single tyrosine phosphorylated protein of 74 kDa again appeared in
the anti-phosphotyrosine Western blot.  This means that either pp55 or pp74 or
both possess a kinase activity.  Cotransfection of SIRP α1, however, abolishes the
radioactive bands in the kinase assay (compare lane 8 with lane 10) and therefore
the coprecipitating kinase activity.  Interestingly, although the kinase activity has
been inhibited by SIRP α1 coexpression, pp74 remains an associated tyrosine
phosphorylated protein and an increased intensity of signal and gel mobility shift
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suggests that it may be even more highly tyrosine phosphorylated, and that a
kinase my be involved in this inhibition.  The next experiment looked to see
whether SIRP α1 coprecipitated with kinase activity.
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Figure 18  Kinase activity associated to SIRP α1.  HEK293 cells were transfected with
pCDNA3/SIRP α1 (lanes 3 and 4), pCDNA3/SIRP α1 Y/F (lanes 5 and 6) or pCDNA3/SIRP β1
(lanes 7 and 8).  Cells were treated with 1mM sodium pervanadate (PoV) for 10 minutes, as
indicated.  SIRP proteins were immunoprecipitated from the lysates with ExF1 antiserum that
recognises both human SIRP α and SIRP β 1 and an in vitro kinase assay was performed using both
enolase and a GST fusion protein of the C-terminal of the src-family kinase Lck that contains the
Y527 inhibitory tyrosine.
Treatment of cells with 1mM sodium pervanadate (PoV) leads to the activation of
at least two kinase activities present in the complex immunoprecipitated by anti
SIRP antibodies (Figure 18).  Enolase, as well as a GST fusion protein of the C-
terminal of src-family tyrosine kinase Lck68 were used as exogenous substrates.
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The C-terminal portion of Lck contains the inhibitory tyrosine (Y527 in c-src) that
inhibits src kinase activity through an intramolecular association with the SH2-
domain when phosphorylated.  The phosphorylation of this Lck-GST fusion protein
is therefore an indication of a kinase activity present that may be able to inhibit src-
family tyrosine kinases.  The activity that is able to phosphorylate the inhibitory
tyrosine in the C-terminal of Lck, is dependent upon tyrosine phosphorylation of
SIRP α because there is no inducible effect when SIRP α1 Y/F is overexpressed
(compare lanes 3 and 4 with lanes 5 and 6).  A second kinase activity can inducibly
phosphorylate enolase, but this is also the case when SIRP α1 Y/F is
overexpressed, suggesting that it associates to SIRP α independently of the ITIMs
in SIRP α.
5.3.4 Stimulation of SIRP β1 complex signalling with mAb
B1D5C3
Since SIRP β1 has no known ligand, it was clear that it would be useful to obtain
an activating SIRP β1-binding antibody that could be added to cells to activate the
SIRP β1 complexes on the surface by coligation.  This would enable the
examination of SIRP β/DAP12 signalling by a more precise method of stimulation.
Empirical results with the self-produced α-SIRP β ex antibody were not
forthcoming (results not shown), therefore, SIRP α1exGST was used in
collaboration with H-J Buehring and M. Seiffert to produce SIRP β1-selective
monoclonal antibodies (mAbs) that may be used in the stimulation experiments
described above.  Figure 19 illustrates the specificity of B1D5C3, one such mAb
that was isolated that successfully immunoprecipitated overexpressed SIRP β1 but
not SIRP α1in HEK293 cells.
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Figure 19 Selectivity of mAb B1D5C3 for SIRP β over SIRP α.  HEK293 cells were
transiently transfected with pCDNA3 (lanes 1-2), pCDNA3/SIRP α1 (lanes 3-4) or pCDNA3/SIRP β1
(lanes 5-6).  Cells were stimulated with 1mM sodium pervanadate (PoV) for 10 minutes.  Lysates
were immunoprecipitated with mAb B1D5C3 (upper panel) or ExC2 polyclonal antiserum (lower
panel). Immunocomplexes were separated on 10% SDS PAGE and proteins were detected in
Western blot with a mixture of SIRP α and SIRP β antisera (α-SIRP).
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The experiment presented in Figure 19 shows that while the α-SIRP β ex
antiserum cannot selectively immunoprecipitate SIRP β1 in favour of SIRP α1,
mAb B1D5C3 recognises SIRP β1 but not SIRP α1.  Therefore mAb B1D5C3 is
indeed selective for SIRP β1.  This mAb was tested in subsequent experiments to
assess its potential as an activating mAb.
To reveal possible tyrosine phosphorylation of SIRP β−associated components via
coligation of the SIRP β/DAP12 complex, mAb B1D5C3 was added to
HEK293/GST-DAP12 cells overexpressing SIRP β1 over a time course varying
from 2 minutes to 1 hour.  The results were analysed by Western blotting with
anti-phosphotyrosine antibodies and are shown in Figure 20.
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Figure 20  Coligation of SIRP β1/DAP12 complex with mAb mAb B1D5C3.  HEK293/GST-
DAP12 cells were transiently transfected with pcDNA3 or pCDNA3/SIRP β1, as indicated.  Cells
were stimulated with 20 µl dialysed B1D5C3 hybridoma supernatants for the times indicated and the
cells were washed twice in PBS before lysis. Lysates were precipitated with GSH sepharose and the
complexes were separated on 8%-16% SDS PAGE.  Tyrosine phosphorylated proteins were
detected in Western blot with anti-phosphotyrosine antibodies.
Figure 20 shows that mAb B1D5C3 is able to bind to SIRP β1.  The two bands of
~28 and ~55 kDa (latter half of the Figure) correspond to the light and heavy
chains of mAb B1D5C3 as they are recognised by the secondary anti-mouse
antibody used in the Western blot.  These bands increase in intensity with time,
and require that SIRP β1 is overexpressed to bind to the cells and come down in
the complex coprecipitated with the GST fusion protein.  The two bands of ~38 and
~40 kDa could be identified as GST-DAP12 by western blotting with α-GST
antibody (middle panel) 69.  These bands are only visible where SIRP β is
overexpressed, but also where there is no stimulation by antibody.  This suggests
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that overexpression of SIRP β1 alone has an effect upon signalling through
DAP12.
 Although mAb B1D5C3 stimulation is weak, at 1 hour Syk is visible as a weak
band in western blot (lower panel).  This suggests that the antibody does have an
effect on signalling through the SIRP β/DAP12 complex.
SIRP α may recruit tyrosine kinases to the SIRP β/DAP12 complex thereby
inhibiting its activity (Figures 17 and 18).  To identify kinases that could modify
GST-DAP12 tyrosine phosphorylation as part of a SIRP α complex, kinase inactive
molecules were overexpressed with SIRP α1 in GST-DAP12 cells transiently
overexpressing SIRP β1. Kinase-inactive CSK and PYK2 were chosen because
they have both been shown to bind to SIRP α20 23. Treatment with mAb B1D5C3
was repeated in case an effect could be seen together with this overexpression.
69
Figure 21  Enhancement of constitutive GST-DAP12 tyrosine phosphorylation by exposure
to kinase inactive molecules.  HEK293/GST-DAP12 cells were transiently transfected with
SIRP β1 (all lanes) together with pCDNA3/SIRP α1 (lanes 7-12) and pCDNA3/CSK K/M (lanes 3-4,
9-10) or pCDNA3/PYK2 K/M (lanes 5-6, 11-12).  Cells were stimulated with 20 µl dialysed B1D5C3
hybridoma supernatants for 30 minutes (even lanes). Lysates were precipitated with GSH
sepharose and the complexes were separated on 8%-16% SDS PAGE.  Tyrosine phosphorylated
proteins were detected in Western blot with anti-phosphotyrosine antibodies.
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The experiment shown in Figure 21 suggests that both a kinase inactive CSK
(CSK K/M) and, to a lesser extent a kinase inactive PYK2 (PYK2 K/M) enhance the
basal tyrosine phosphorylation of GST-DAP12.  This tyrosine phosphorylation is
probably independent of treatment with mAb mAb B1D5C3, and is also
independent of SIRP α1 overexpression.  Overexpression of SIRP α1, on the other
hand inhibits the tyrosine phosphorylation of GST-DAP12.  This is reminiscent of
the experiment (Figure 17) where overexpression of SIRP α1 inhibits the kinase
activity of Syk but enhances its tyrosine phosphorylation. Nevertheless co-
overexpression of either CSK K/M or PYK2 K/M does not influence this.  Therefore
neither of these kinases can be implicated in GST-DAP12 phosphorylation from
this experiment.
Because mAb B1D5C3 may therefore not be effective as a tool to elicit signalling
through SIRP β/DAP12 in HEK293 cells, these experiments were discontinued.
5.4 Cellular Localisation of SIRP β and DAP12
Overexpression of SIRP β1 in GST-DAP12 cells (Figure 20) induces
phosphorylation of GST-DAP12.  This may be due to an influence upon the
subcellular localisation of DAP12 by SIRP β1. To test this hypothesis, the
localisation of overexpressed GFP fusion proteins of SIRP β1 (SIRP β1-GFP,
Figure 22) and DAP12 (DAP12-GFP, Figure 23) were examined in NIH3T3 cells.
To compare the influence of SIRP β1 on localisation of DAP12, overexpressed
DAP12-GFP was compared with and without overexpressed SIRP β1 (Figure 23).
Images representative of typical positive transfectants are presented below.
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5.4.1 Subcellular localisation of SIRP β1-GFP
Figure 22  Representation of pCDNA3/SIRP β1-GFP expression in NIH3T3 cells.  NIH3T3 cells
transiently transfected with pCDNA3/GFP vector expressing either GFP alone (left panel) or a
SIRP β1-GFP fusion protein (right panel).  ).  Cells were fixed in paraformaldehyde and nuclei were
stained with DAPI (blue)  (DAPI: λex=358 nm, λem=461nm).  Protein expression (green) was
visualised by fluorescence microscopy (GFP λex= 495 nm, λem=525 nm).
When cells were transfected with pCDNA3/ SIRP β1-GFP, there were far fewer
cells that visibly expressed a GFP-fusion protein than when GFP was expressed
alone.  The distribution of SIRP β1-GFP is perinuclear, and granular in distribution,
suggesting a localisation in the endoplasmic reticulum.  Little SIRP β1 was present
in the cell membrane.
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5.4.2 Comparison of localisation of DAP12-GFP with and without
SIRP β1
Figure 23  Translocation of DAP12 to the cell membrane after SIRP β1 coexpression.  The
picture compares NIH3T3 cells transiently transfected with pCDNA3/DAP12-GFP either alone (left)
or pCDNA3/DAP12-GFP cotransfected with pCDNA3/SIRP β1 (right).  Cells were prepared and
analysed as described in Figure 22.
Cells expressing DAP12 following transfection with pCDNA3/DAP12-GFP are also
fewer in number than GFP.  Where a signal is found, the cellular localisation is also
perinuclear, although with a different appearance to that of SIRP β1 (compare
Figure 23 with 22). It is known that the coexpression of SIRP β influences the
cellular distribution of DAP12, causing DAP12 to migrate to the cell membrane
where it has been detected using FACS 70.  This is confirmed by overexpression of
SIRP β1 together with DAP12-GFP (Figure 23).  The influence on the localisation
of DAP12 is visible when the left and right pictures are compared, with significantly
more DAP12-GFP localised to the membrane.
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5.4.3 DAP12 membrane translocation affects its signalling
potential
Experiments with overexpression presented in previous sections have suggested
that SIRP β1 influences both the tyrosine phosphorylation and subcellular
distribution of DAP12.  The following experiment confirms that this translocation to
the cell membrane places DAP12 within the proximity of tyrosine kinases.  SIRP β1
was overexpressed in DAP12-GST cells, and the cells were treated with sodium
pervanadate to inhibit tyrosine phosphatases.  To confirm the inhibitory effect of
SIRP α molecules upon the SIRP β/DAP12 complex, SIRP α1 was also expressed.
Tyrosine phosphorylation of DAP12 was assessed in western blot with
anti-phosphotyrosine antibodies.
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Figure 24  Repositioning of DAP12 at the cell membrane following SIRP β1 overexpression
places it within the vicinity of tyrosine kinases.  HEK293/DAP12-GST cells transiently
overexpressing SIRP β1 (lanes 3-6), and SIRP α1 (lanes 5-8) stimulated with 1mM sodium
pervanadate (PoV) for 10 minutes.  DAP12-GST was precipitated from cell lysates and proteins
were separated on 12% SDS PAGE tyrosine phosphorylated proteins were detected in Western blot
with anti-phosphotyrosine antibodies.
When HEK293/DAP12-GST cells are transfected with SIRP β1 and treated with
sodium pervanadate, DAP12-GST is far more strongly tyrosine phosphorylated
than when SIRP β1 is not overexpressed.  When SIRP α is coexpressed with
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SIRP β1, there is an inhibition of DAP12-GST tyrosine phosphorylation, although
this is not strong enough to reverse the effect of SIRP β1 overexpression.
Differences are also seen in tyrosine phosphorylation of the coprecipitating band
likely to be Syk (see Figure 14), but it is not possible to tell whether this is due to
tyrosine phosphorylation of DAP12-GST (essential for association of Syk) or of the
protein itself.
5.4.4 Dependence of DAP12 upon SIRP β1 coexpression and
vice versa
To address the potential biological consequences of a collaborative signalling
complex formed between SIRP β and DAP12, NIH3T3-derived cell lines were
prepared stably-expressing either SIRP β or DAP12 or both.  To minimise the
cytotoxic insult produced by sequential infections and multiple antibiotic selection
procedures, a vector was derived from pLXSN that possessed an internal
ribosomal entry site (IRES) in the middle of the multiple cloning site (MCS),
enabling two flanking ORFs to be cloned (section 5.4.1.1).  The vector (termed
pIRES) is then able to express two sequences of interest as a bicistronic transcript,
resulting in both ORFs being theoretically transcribed in a 1:1 molar ratio.  An
interesting phenomenon was observed upon testing these constructs in transient
transfection in HEK293 cells (Figure 25).
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Figure 25  Expression of SIRP β is higher when DAP12 is present, and vice versa.  HEK293
cells transfected with pLXSN (lane 1), pLXSN/DAP12 (lanes 2 and 4), pLXSN/SIRP β1 (lanes 3 and
4), and pIRES/SIRP β1 + DAP12 (lane 5).  Cells were lysed in standard 0.1% Triton X-100 lysis
buffer and balanced quantities of protein were loaded onto 8%-16% SDS PAGE.  Proteins were
detected in Western blot using α-SIRP β antibodies (top panel) and α-Flag antiserum (lower panel).
The experiment shown in Figure 25 shows the surprising result that SIRP β1 or
DAP12 are only detectable in Western blot when accompanied by each other.
Moreover, signal intensity of both SIRP β1 and DAP12 are increased when the
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pIRES vector is used compared to when plasmids with single inserts were
cotransfected (compare lanes 4 and 5).  This is probably due to efficiency of
transfection, i.e. not all cells successfully transfected contain both plasmids.  This
supports the hypothesis that both proteins are required for the sustained
expression of either partner.  There is no significant difference in this result when a
RIPA buffer is used (not shown) instead of Triton X-100 lysis buffer for cell lysis so
it is likely that DAP12 affects the SIRP β signal in Western blot by influencing its
presence in the cell and not its subcellular localisation.
5.4.5 SIRP β membrane localisation depends upon DAP12
The influence of SIRP β upon the subcellular localisation of DAP12 has now been
addressed, but not how this affects the distribution of SIRP β1 in the cell.  At high
levels of overexpression, SIRP β1-GFP is perinuclear, probably in the endoplasmic
reticulum (Figure 22).  If SIRP β escorts DAP12 to the membrane, it is likely that
SIRP β1 would also be present in the cell membrane when DAP12 is
overexpressed.  To assay the subcellular localisation of SIRP β1 at lower levels of
overexpression similar to those that produced the effect seen in Figure 25,
immunofluorescence with mAb B1D5C3 was necessary (Figure 26).
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Figure 26  Stability of SIRP β1 relies upon the coexpression of DAP12.  NIH3T3 cells
transfected with different pLXSN constructs (as indicated in the Figure) incubated with mAb B1D5C3
to detect overexpressed SIRP β1.   Antibody was detected by incubation with CY3 (red) coupled
goat-anti-mouse antibody and visualised by immunofluorescence microscopy (λex=552 nm, λem=570
nm).  Nuclear DNA was stained by DAPI (blue) (DAPI: λex=358 nm, λem=461nm).
Use of the mAb B1D5C3 in immunofluorescence confirms that at lower expression
levels, SIRP β1 is undetectable in the cell.  When DAP12 is also overexpressed,
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SIRP β1 expression is stabilised, fitting with the experiment shown in Figure 25,
and localised to the plasma membrane.  The subsequent experiment shown in
Figure 27 suggests that SIRP β may exit the cell when not tethered to the
membrane through its association with DAP12.
Figure 26 confirms the evidence presented in the previous figures with
immunofluorescence.  SIRP β1 can only be visualised when both SIRP β1 and
DAP12 are expressed together in the cell.  The localisation of SIRP β1 is
principally at the membrane, suggesting that SIRP β1 moves from the ER to the
membrane with DAP12 (see Figure 23). Additionally, it appears that the signal is
stronger at points of cell-cell contact (bottom-left picture) that may point to a role in
intercellular communication.
The intracellular domains of single-pass transmembrane proteins often serve as
anchors that prevent their secretion into the extracellular milieu. SIRP β1 has no
intracellular domain, but travels to the plasma membrane with DAP12.  If SIRP β
progressed to the cell membrane in the absence of DAP12, it may therefore be
secreted.  Alternatively, SIRP β may be restricted in the ER.  Both situations would
produce the result seen in Figure 22.
To determine whether the fate of SIRP β in the absence of DAP12 lies in the ER or
in the extracellular milieu, SIRP β1 was overexpressed with or without DAP12, and
cell lysates as well as cell culture supernatants were tested for the presence of
SIRP β.
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Figure  27  Secretion of overexpressed SIRP β is impeded by DAP12 overexpression.
HEK293 cells transfected with pLXSN constructs overexpressing SIRP β1 (lanes 2-3, 6-7) and
DAP12 (lanes 3,7) or with pCDNA3/SIRP α1 (lanes 4 and 8).  SIRP α1 was immunoprecipitated
from balanced cell lysates (lanes 1-4) or equal volumes of cell culture medium (lanes 5-8).  Proteins
were separated on 10% SDS PAGE and detected in Western blot using anti-SIRP β antibodies.
When SIRP β1 is overexpressed under the control of a strong CMV promoter (as in
Figure 22), abundant quantities of SIRP β1 are found in the supernatant fraction
(lane 8).  Even at LTR-driven levels, however, SIRP β1 is detectable in the
supernatant (lane 6).
81
SIRP β1 expression in cell lysates is increased or stabilised when DAP12 is co-
expressed while it is reduced in the supernatant (compare lanes 2-3 and 6-7).  The
data suggests therefore that overexpressed SIRP β1 is passively secreted, and
that coexpression of DAP12 restricts SIRP β1 secretion by anchoring it in the cell
membrane.
5.5 Caveolar Localisation of SIRP proteins
SIRP β1 and DAP12 were both detected at the cell membrane when both
expressed, and there was an inhibitory influence of SIRP α upon the
SIRP β/DAP12 complex.  It was therefore theorised that both subtypes may
operate in close proximity in the cell.
SIRP α are thought by some to be scaffold proteins23, and are involved in the
signalling of many proteins (e.g. RTKs, src-family kinases) that are found in
organised raft structures, or caveolae.  Caveolae are subcellular structures in the
plasma membrane thought to be responsible for the spatial organisation of
multiprotein complexes in signal transduction71.  It was decided to test for the
presence of SIRP family members in caveolae.
Two methods were employed to isolate caveolar fractions from the rest of the cell
membrane.  In both cases, caveolae-containing fractions were identified using an
antibody raised against the caveolar marker protein, Caveolin1.
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Figure 28  Separation of Triton-X-100 insoluble fractions on sucrose density gradient.  Sub-
confluent MCF-10A cells growing in medium with 10% serum were lysed in buffer Triton-X100 and
the lysates were separated by sucrose density gradient ultracentrifugation.  Fractions of 0.5 ml were
taken from the top of the tube (fraction 1) to the bottom (fraction 15).  Fractions were separated on
8% - 16% SDS PAGE and proteins were detected in Western blot with polyclonal antisera
recognising SIRP α  (top panel) and Caveolin1 (bottom panel).
Figure 28 shows that SIRP α is not enriched in caveolae-containing fractions
(fractions 10-12) prepared by lysing cells in Triton-x-100 and separating the
buoyant insoluble fraction from the pellet by density gradient ultra centrifugation.
The fractions containing caveolae are identifiable by the intensified Caveolin1 signal
in the Western blot (lower panel, lanes 10-12).  The total extent of the detectable
SIRP α signal resides, however, in the pellet (fractions 14 and 15) as is clear in the
upper panel.  However, there is evidence that this method of caveolus isolation has
a disruptive effect on its structural integrity because many more proteins can be
found in the caveolar fractions prepared using detergent-free methods71.
To find out whether or not SIRP family proteins can be found in the Triton X-100 –
soluble component of the caveolus, a detergent-free method was used.
This method involved homogenising cells and separating the plasma membrane
fractions from the remainder of the cellular material on a Percoll gradient.  The
plasma membrane is then sonicated and the buoyant, Caveolin1-containing
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fractions are separated from the remainder of the plasma membranes on a second
Optiprep gradient.
Figure 29  SIRP proteins are present in caveolae-containing fractions.  Representative fractions
are depicted from detergent-free isolation of Caveolin-containing fraction of MCF10A cells growing in
medium with 10% serum. Fractions were separated with 8% to 16% SDS PAGE.  Loading of lanes
was balanced for representative initial cellular content.  Lane 1, crude cell lysates prepared by
treatment of cells with 1% SDS lysis buffer.  Lane 2, plasma membranes isolated by Percoll gradient
separation.  Lane 3, buoyant fraction following sonication of membranes and separation by Optiprep
gradient.  Lane 4: remainder of plasma membrane fraction after removal of buoyant fraction.
Caveolae-containing fractions produced by this method contain SIRP α molecules
because SIRP α proteins are clearly enriched with Caveolin1 in the same fraction
(Figure 29).  Antibodies against SIRP α also detected a diffuse signal between ~45
and ~66 kDa, which is the size of SIRP β.  This suggests that SIRP proteins are
indeed part of the contents of the raft, or caveolus.
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5.6 Biological Effects of the SIRP β/DAP12 complex in NIH3T3
cells
5.6.1 NIH3T3 derived cell lines overexpressing SIRP β/DAP12
Since coexpression of SIRP β1 and DAP12 are needed to establish a stable
complex at the cell membrane, study of biological potential is best achieved by
comparing cell lines possessing both SIRP β and DAP12 with mock transfected
cell lines.  To this end, NIH3T3 cells were infected with either the empty pIRES or
pIRES/SIRP β1+DAP12.  Stable G418-resistant monoclonal cell lines were
screened for expression of both SIRP β1 and DAP12 and three clones with
detectable expression of both proteins were chosen and compiled into one
oligoclonal cell line (SD469) with the advantages of the enhanced stability of
expression of the gene of interest associated with a monoclonal cell line and the
reduced likelihood of artefacts associated with a polyclonal cell line (Figure 30)
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Figure  30 The six clones used to produce the two NIH3T3-derived oligoclonal cell lines
X123 and SD469.  NIH3T3 cells were infected with pLXSN (left block) or pIRES/SIRP β1+DAP12
(right block).  Cells were selected in G418 for 14 days, then dispersed sparsely over fresh plates.  10
clones were picked and grown in isolation.  Each clone was tested by Western blotting with
antibodies against SIRP β (upper pictures) or DAP12 (lower panel).  The oligoclonal cell line X123 is
a compilation of the three monoclonal pLXSN-infected clones 1,2, and 3. The SIRP β1/DAP12-
overexpressing cell line SD469 is a compilation of the monoclonal pIRES/SIRP β1+DAP12-infected
clones 4,6,and 9 (see above).
Two phenotypic observations could be distinguished in the NIH3T3 cells
overexpressing SIRP β and DAP12 (SD469) from the control cell line (X123): a
resistance to induced-cell death and enhanced rate of acid production.  These
observations are described in the following sections, where for the purposes of
simplicity are sometimes collectively referred to as the “SD469 phenotype”.
5.6.2 Resistance to cell death induced by different stimuli
5.6.2.1 TNFα stimulationAB86
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Figure 31 Resistance of an NIH3T3-derived cell line overexpressing both
SIRP β1/DAP12 (SD469) to TNFα-induced cell death.  (A)  Comparison is with that of a control cell
line (X123).  2.5x103 cells were seeded in 96-well plates and grown for 48 hours.  Cells were starved
for 18 hours in medium containing 0.5% serum before stimulation with indicated quantities of TNF α
in the presence of actinomycin D.  After a further 18 hours, viable cells were measured by MTT
assay and are presented as a percentage of the untreated value. (B)  Samples treated in the same
manner were seeded on cover slips, fixed, and stained with DAPI.  The nuclei were examined by
fluorescence microscopy (lower pictures).
 Figure 31 shows that SD469 are resistant to TNFα-induced cell death when
compared with a mock-infected cell line (X123).  Experiments with other
established apoptosis-inducing conditions were performed to determine the
specificity of this effect for TNFα.  The lower part of the Figure illustrates through
the examination of the nuclei after DNA staining with DAPI that treatment with
TNFα leads to the nuclear condensation (which is characteristic of the onset of
apoptosis) to a far greater extent in control cells than in cells overexpressing
SIRP β/DAP12.
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5.6.2.2 Depletion of serum
Figure 32  Culture of control (X123) or SIRP β/DAP12 overexpressing NIH3T3 cells in DMEM
medium containing different serum concentrations.  X123 or SD469 cells were grown for 8 days
in DMEM medium with 4 different concentrations of serum.  After each day, the number of viable
cells was measured by MTT assay and represented as a percentage of the initial cell number.
When cells are grown at serum concentrations of 0.5% or 1%, there is a
divergence in the viability of the two different cell lines after 4 days (Figure 32).
The control cells (X123) appear to lose viability, while the cells overexpressing
SIRP β1/DAP12 are able to survive for longer.  This effect may be accredited to an
inhibition of apoptosis concurrent with the experiment result shown in Figure 31.
While this effect is visible at lower serum concentrations, it is overcome at higher
concentrations, suggesting that what is being measured is the response to a stress
stimulus upon the cells and not representative of the overall fitness of the cells.
89
5.6.2.3 Ultraviolet (UV) irradiation
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Figure 33  Resistance of cells overexpressing SIRP β1/DAP12 to UV-induced cell death with
respect to control.  Cells were seeded in 96-well dishes (2000 per well) and exposed to the UV light
of a cell culture laminar flow for increasing periods of time.  The cells were left overnight and an MTT
assay was performed the following morning to assess cell viability, which was presented as a
percentage of the viability of untreated cells.
Although a weaker effect is produced by UV irradiation, there is nevertheless a
trend to represent a resistance to UV-induced cell death in cells overexpressing
SIRP β1/DAP12.
5.6.3 Influence of inhibitors on resistance to cell death
Since treatment by TNFα was the most convenient and effective way to induce cell
death in this system, all subsequent experiments were performed using TNFα
treatment.  The experiments were repeated in the presence of inhibitors of PI-3K
and src-family kinases to try to implicate them in the mechanism leading to this
phenotype.
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5.6.3.1 PI-3K inhibitor Wortmannin
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Figure 34  Resistance of SIRP β1/DAP12 overexpressing cells to TNFα-induced cell death is
unaffected by Wortmannin treatment.  Cells were grown in DMEM containing 10% serum,
starved in DMEM containing 0.5% serum then stimulated overnight in medium containing 20 ng/ml
TNFα and 500 ng/ml Actinomycin D.  Wortmannin was included in the medium to an end
concentration of 5µM where indicated. Viable cell number was measured using the MTT assay and
assessed as a percentage of that of untreated cells.
Since there is a biochemical link between the activity of Syk and phosphoinositide
3-kinase (PI-3K), and that PI-3K activates protein kinase B, or Akt, the activation of
which is, in turn, able to inhibit apoptosis through the Bcl/Bax family of proteins,
one may hypothesise the involvement of PI-3K in the resistance to induced cell
death.  Incubation with the classical inhibitor of PI-3K, however, is ineffective in
abrogating this resistance to apoptosis, (Figure 34) suggesting that
SIRP β1/DAP12 does not produce these effects using this pathway.
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5.6.3.2 Src-family kinase inhibitor PP1
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Figure 35  Resistance of cells overexpressing SIRP β1/DAP12 to TNFα-induced cell death is
inhibited by high concentrations of PP1.  Cells were grown in DMEM containing 10% serum,
starved in DMEM containing 0.5% serum then stimulated overnight in medium containing 20 ng/ml
TNFα and 500 ng/ml Actinomycin D.  PP1 was included in the medium to an end concentration of
80 µM where indicated. Viable cell number was measured using the MTT assay and assessed as a
percentage of that of untreated cells.
Although Wortmannin was unable to suppress the resistance of SIRP β1/DAP12
overexpressing cells to TNFα-induced cell death, treatment of cells with the src-
family kinase inhibitor was successful, and the inhibition of the phenotype
increased in a dose-dependent fashion, although the effects began at PP1
concentrations higher (8-fold) than necessary to inhibit src-family kinases, the
established concentration being 10 µM.
5.6.4 Role of Syk in resistance to cell death
Following the identification of Syk as a member of the SIRP β/DAP12 complex it
was necessary to determine the role, if any, that Syk may be playing in cell death
resistance by overexpressing a kinase inactive form of Syk.
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To this end, the ORF of Syk was cloned from cDNA by PCR, and a K402R
substitution was produced by site-directed mutagenesis that removes the ATP-
binding site of the protein and hence abolishes the kinase activity.  The plasmid
clones following the in vitro mutagenesis were overexpressed in HEK293 cells and
tested for the kinase activity of the expressed protein.
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Figure 36  Construction of a kinase-inactive Syk.  Syk was amplified by PCR cloning from cDNA
prepared from HEK293 cells.  The coding region was subcloned into pCDNA3 and the lysine at
position 402 was mutated to an arginine to produce pCDNA3/Syk K402R by site-directed in vitro
mutagenesis. HEK293 cells were transiently transfected with pCDNA3, pCDNA3/Syk or
pCDNA3/Syk K402R as indicated.  Cells were stimulated with 1mM sodium pervanadate (PoV) for
10 minutes before lysis.  Proteins were separated on 10% SDS PAGE and detected in Western blot
with anti Syk antiserum (left picture) or anti-phosphotyrosine antibodies.
Overexpression of Syk in HEK293 cells leads to the increased tyrosine
phosphorylation of a large number of proteins, ranging mainly from 87 kDa to 45
kDa (Figure 36, left picture).  Inhibition of tyrosine phosphatases by sodium
pervanadate treatment enhances this effect greatly.  In contrast, there is very little
tyrosine phosphorylation produced latently by Syk K402R and pervanadate
treatment produces a range of tyrosine phosphorylated proteins that is reduced
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with comparison to pCDNA3-transfected cells.  It is concluded from this evidence
that Syk K402R is kinase-inactive.
To test the influence of Syk on the resistance of SIRP β1/DAP12 overexpressing
cells to TNFα-induced cell death, polyclonal cell lines were produced by
transfecting either X123 or SD469 cells with pCEP4, pCEP4/Syk or pCEP4/Syk
K402R.  Cells were selected with hygromycin, and tested for their reaction to TNFα
stimulation (Figure 37).
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Figure 37  Overexpression of wt Syk in NIH3T3 control cells is sufficient but not necessary to
reproduce the SD469 phenotype.  The figure represents the response of the six stable cell lines
(legend, top-right) to treatment with different concentrations of TNFα.  The different treatments were:
“A”(500 ng/ml actinomycin D), A+5 (actinomycin D+ 5ng/ml TNFα), “A+20” (actinomycin D + 20 ng
TNFα) and “A+100” (actinomycin D + 100 ng/ml TNFα). Cells were treated overnight and cell
viability was quantified using the MTT assay and represented as a percentage of that of the
untreated cells.
Figure 37 shows two distinct trends produced from the cytotoxicity assay.  The
resistance of SIRP β1/DAP12 overexpressing cells to TNFα-induced cell death is
reproduced in the mock-transfected X123 and SD469 cells.  Secondly, kinase-
inactive Syk overexpression does not alter the phenotype of the cells in either
X123- or SD469-derived cell lines.  However, overexpression of Syk in X123 cells
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produces a similar resistance to TNFα as SD469 cells.  The resistance produced
by SD469 cells is not, however, enhanced by overexpression of Syk.  This
suggests that overexpression of Syk is sufficient but not essential for resistance to
TNFα-induced cell death, and therefore that the effect produced by
SIRP β1/DAP12 overexpression may operate via a different pathway.
5.6.5 Enhanced glucose metabolism
While the SD469 and X123 cells were in culture, a difference in colour of the cell
culture medium was observed.  Measuring the pH of the medium disclosed a clear
difference after two days of culture (Figure 38).
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Figure 38  Enhanced acid production in NIH3T3 overexpressing SIRP β/DAP12 with
comparison to control.  Confluent X123 (A and B) or SD469 (C and D) cells were cultured for 48
hours in DMEM medium containing either 1000 mg/l glucose (A and C) or 4500 mg/l (B and D)
glucose.  The pH of the medium was measured with a Microprocessor pH/Ion meter (WTW pMX
3000). The colour of the cell culture medium was photographed for illustration.
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The drop in medium pH over two days of culturing SD469 was significantly greater
than in X123 cells that was inhibited when the cells were incubated in medium with
a lower concentration of glucose.  This enhanced rate of production of acid into the
cell culture medium therefore suggests a higher rate of glucose metabolism that
would suggest enhanced rates of glycolysis.
To establish whether enhanced acid production maybe reflected a higher rate of
glucose usage, glucose uptake was measured.  Cells were additionally stimulated
with PDGF, which has been established to induce glucose uptake in NIH3T3
cells72.
Figure 39  Enhanced glucose uptake in cells overexpressing SIRP β/DAP12.  X123 or SD469
cells were stimulated with or without PDGF B/B in the presence or absence of 5 µM Wortmannin for
1 hour (50ng/ml final concentration) after which 3H-2-deoxy-D-glucose was added to a final
concentration of 5µCi/ml.  After 5 minutes cells were washed and lysed and incorporation of 3H was
measured.
The experiment above suggests that enhanced acid production occurs
concomitantly with a slightly enhanced rate of glucose uptake.  This was
insensitive to Wortmannin, suggesting that PI-3K was not involved in this effect.
Additionally, in contrast to enhanced glucose uptake following treatment of X123
with PDGF, SD469 appear to be insensitive to PDGF stimulation.
98
6 Discussion
6.1 Association of SIRP α extracellular domain with CD47 and
other molecules
The role of the extracellular domain was addressed by the use of eukaryotically
produced SIRP extracellular domain GST fusion proteins in adhesion assays.
The results revealed little difference between the adhesion properties of SIRP α1
and SIRP α2.  These two SIRP α family members are 98.5% identical in primary
protein sequence, only 13 amino acids are different, and of these, only 7 produce a
change in the charged nature of the amino acid side chain.  All of these
substitutions are in the extracellular domain of the protein, however, the binding
characteristics of SIRP α1 and SIRP α2 means that these differences are not
sufficient to cause the binding specificity to differ between the two SIRP α family
members.
SIRP β1 also shares a high degree of identity in primary protein sequence to
SIRP α1 and SIRP α2 though not quite as high as that between SIRP α1 and
SIRP α2.  With the exception of the secretory signal peptides, which are totally
different and are probably cleaved in the mature protein, SIRP β1 is 90% identical
and 94% similar to SIRP α1 in the extracellular domain.  These differences are
however, enough to bring about differences in the binding specificity of SIRP β1,
as seen in the cell adhesion experiments performed here.  The confirmation that
SIRP α1 and SIRP α2(not shown) but not SIRP β1 bind to CD47 also illustrates
this. Therefore, small differences that are evident amongst all SIRP family
members can in some cases bring about altered ligand specificity.  Ligand affinity
could also be modified by different patterns of glycosylation.  Of the amino acid
differences between SIRP β1 and SIRP α1, at least one of them either creates or
destroy a potential glycosylation site Both primary sequences contain the putative
N-glycosylation motif NXS/T 735 times at the same position, however, there is an
extra N-glycosylation site at amino acid position 105 of the SIRP β1 sequence that
is not present in SIRP α1.
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The difference between the adhesion characteristics of GST-fused and IgG-fused
extracellular domains of the same family member must be explained.  The internal
control, GST, produced little or no cell adhesion.  Additionally, neither
SIRP β1exGST nor SIRP β1exIgG supported cell adhesion.  This shows that the
cells are binding to the SIRP extracellular domains and not to either of the tags.
Therefore, something else produces the difference in some cell lines between
SIRP αexGST and SIRP αexIgG.
The method of purification of the GST fusion proteins is different to that of the IgG
fusion proteins and may provide the answer.  After binding to the affinity column,
the GST fusion protein is eluted by soluble glutathione, which competes with the
glutathione bound to the column for active sites on the GST tag.  The GST fusion
protein is therefore removed by a method that does not involve denaturation of the
protein.  However, the IgG fusion proteins are eluted with a low pH buffer, which
disturbs charged interactions between the side chains of the bound protein and its
ligand.  The buffer is subsequently neutralised to return the protein to its original
state.  The conformation of a protein can also be stabilised by intramolecular
interactions between charged amino acids.  Disrupting these interactions might
force an irreversible change in the conformation of the protein - a partial
denaturation.
Despite this putative denaturation, in most cases both SIRP α1exGST and
SIRP α1exIgG support cell adhesion equally well.  However, when certain cell
lines are used, adhesion is abolished.  If SIRP α had only one ligand, mild
denaturation would produce an overall reduction in affinity for the ligand and the
adhesion pattern of the IgG fusion proteins would reflect those of the GST fusions
but with weaker binding.  As we have seen, this is not the case here.  The actual
situation would be explainable if there were two different ligands (Ls and Li) binding
to SIRP α molecules at different sites (Bs and Bi, respectively).  If Bs was sensitive
to treatment at low pH and unable to renature, but Bi was insensitive to the
treatment, the IgG fusions would only be able to bind to Li while the GST fusions
would still bind to Ls and Li.  The difference in adhesion pattern would therefore be
representative of the relative expression of Ls.
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The adhesion of OV10/x cells not expressing CD47 to SIRP α1exGST can be
explained by this theory.  CD47 would be Li , the ligand for the insensitive binding
site,  because both SIRP α1exGST and SIRP α1exIgG support adhesion of OV10/
CD47.  But cells that adhere to SIRP α1exGST despite the absence of CD47
would be expressing Ls, the ligand for the sensitive binding site(Bs).  According to
the theory OV10 do not adhere to SIRP α1exIgG because Bs was destroyed during
elution.
The likelihood that SIRP α has more than one ligand is supported by other
characteristics of SIRPs:  The existence of a family of proteins that differ only very
slightly in their primary sequence suggests a protein-ligand relationship that is
subtly specific, and may involve contact with another family with a similar degree of
polymorphism.  The existence of a potential splice variant of SIRP α that lacks the
second and third c-type Ig-like loops provides additional evidence for more than
one ligand for SIRP α.  Assuming that this region is responsible for an inter- and
not intramolecular association, this splicing is likely to remove at least one binding
site for another molecule.
CD47, also known as ‘integrin associated protein (IAP)’, was recently identified by
others and ourselves21,74 as a ligand for SIRP α.  It is a five transmembrane-
spanning glycoprotein present in a variety of cells of neural and haematopoietic
lineage and other tissues and is co-expressed with SIRP α in retinal cells75.  The
pre-mRNA is alternatively spliced leading to protein isoforms with intracellular
deletions of different sizes47,76-78.  CD47 has been implicated in cell adhesion and
transepithelial cell migration.  Apart from SIRP α, it also associates with the αvβ3
integrin (vitronectin receptor) 79, ‘proteins linking IAP with the cytoskeleton’ (PLICs)
and thrombospondins47.  The interaction between SIRP α and CD47 has now been
implicated in a number of processes.
Amongst other haematopoietic cells, CD47 is also expressed in red blood cells.
Oldenborg et al.80used erythrocytes from a CD47 knockout mouse to show that
normal macrophages, which express SIRP α, kill red blood cells that have no
CD47 expression.  The authors speculate that CD47 is a ‘marker of self’ that the
immune system uses to distinguish self from non-self. However, this is likely to be
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understating the role of the CD47/SIRP α interaction because it is probably
involved in other systems.  First of all, both CD47 and SIRP α are expressed
outside the haematopoietic system, notably the brain.  A bi-directional signalling
relationship involving SIRP α and CD47 has been discovered in the retina75, for
example.
Other models involving the interaction between SIRP α and CD47 have been
studied within the haematopoietic system.  Macrophages express both CD47 and
SIRP α, and one study proposed that the interaction between them facilitated
macrophage fusion and multinucleation81,82.  There are also hints that the same
interaction may facilitate transendothelial cell migration 21.
Although the interaction has not been precisely characterised, the binding site for
CD47 has been mapped to the N-terminal Ig-V like domain of SIRP α83.  CD47
does not belong to a family of closely related molecules like SIRP α so its binding
is probably not influenced by the subtle variation between SIRP α family members.
It has to be assumed, of course, that the variation among SIRPs has functional
significance, and is not the result of passive degradation following a recent gene
duplication event.  With this in mind, it is interesting to speculate upon other
possible ligands for different SIRP α molecules.  Different SIRP α family members
may have altered specificity for other transmembrane spanning molecules that
belong to a family with similar variety in the extracellular domain.  A similar
hypothesis has already been speculated about the KIR family and different species
of MHC class I ligands84. SIRP α resides constitutively in a complex with the CSF-
1 receptor in macrophages22 and SIRP α may bind to the PDGFR itself85 so certain
RTKs of the PDGFR family, which are also Ig-superfamily members, could
therefore be candidate ligands for SIRP α molecules.
Adhesion assay experiments suggest that CD47 is not a ligand for SIRP β,
because SIRP β1exGST does not support adhesion of OV10/CD47 cells.  This
may be true, but it has to be assumed when one draws this conclusion that the
SIRP β1exGST and SIRP β1exIgG really resemble the native SIRP β in the
extracellular domain.  SIRP β  associates to DAP12, which is a dimeric molecule,
and therefore has two binding sites for a SIRP β.  A functional SIRP β/DAP12
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complex may therefore be tetrameric, containing 2 SIRP β molecules that are close
together and spatially aligned. If this is necessary for effective ligand binding, the
situation is very probably not reflected by immobilised GST fusion proteins.
While most tested cell types were able to adhere to SIRP α1exGST and
SIRP α1exIgG, only one cell type showed any adhesion to SIRP β1exGST, and no
cells could adhere to SIRP β1exIgG.  This could either mean that SIRP β has no
ligand, or that the affinity or avidity of SIRP β for its putative ligand is below the
detection threshold of adhesion assay.  Northern and Western blotting data 70
suggest that SIRP β is a weakly expressed protein in all cell types studied.  If
SIRP β contacts a ligand unique for itself, one would expect that the ligand might
be expressed at a similar level.  In this case, the affinity of a putative ligand for
SIRP β1exGST may be below the detection threshold of the adhesion assay, even
if the concentration of SIRP β1ex were high.  If this were the case, expression
cloning in the manner by which CD47 was isolated as a ligand for SIRP α 74 would
be a realistic option because the ligand would be overexpressed and the avidity
would be enhanced.
Although SIRP α contact with its ligand is often strong enough to sustain cell
adhesion in an adhesion assay, this contact probably does not occur in isolation in
vivo, but together with a number of different coreceptors each contacting their own
ligands, leading to a much stronger cytostructural affinity.  Indeed, SIRP α-ligand
interactions may not play structural roles, but signalling roles on the cell to elicit a
program of cell adhesion.  In this context, it is easy to bring in the possible role of
the SIRPs as ‘cellular signposts’ on the surface of the cell, indicating perhaps to a
migrating lymphocyte or extending axon that it is in the right or wrong place, and
aiding to direct it accordingly.
It is tempting in this context to consider SIRP β as a possible chemorepellant
because of two observations.  To say that SIRP β1exGST or SIRP β1exIgG did not
support cell adhesion was in many cases understating the case.  In adhesion
assay using rapidly-spreading cells such as fibroblasts, if the plate was left longer,
the cells would begin to adhere even to the BSA blocking protein.  This is not
unusual in cells that secrete their own matrix proteins.  In these cases SIRP β1ex
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supported less adhesion even than the BSA blocking substrate.  Although only a
hint, searching for a role in cell migration might be promising for SIRP β.  Since
SIRP β may be a secreted protein under certain circumstances, and this would
also support a role in chemotaxis.
The extracellular domains produced for use in adhesion assays also proved useful
as antigens for immunisation.  The secretion system yielded enough protein to
construct affinity columns to purify specific antibody from the serum.  An added
advantage over bacterially produced GST fusion proteins of extracellular domains
was that the antibody was raised against a eukaryotically-processed and
glycosylated protein, and hence may recognise more physiologically-relevant
epitopes.  Considering the very high sequence identity between SIRP α1 and
SIRP β1 in their extracellular domains, the antisera were very selective for their
respective antigen.  The fact that the antisera showed this selectivity is probably
because if other aspects of the structure besides the primary peptide sequence, for
example, different glycosylation patterns.    Since glycosylation is not only a
sequence-specific but also a tissue- and cell type-specific phenomenon, the variety
in final structure may be wider in vivo than in the situation here, where the proteins
were secreted from the same cell type  (HEK293).
In conclusion to this section, it has been found that members of the SIRP family do
have relevance to cell adhesion and adds a functional aspect to the structural
relationship it has with the C-CAM members of the CEA superfamily.
6.2 Regulation of SIRP α by tyrosine kinases
The PP1 inhibition of SIRP α tyrosine phosphorylation induced by EGF and other
ligands indicates that although SIRP α tyrosine phosphorylation is triggered by
stimulation of a wide variety of different receptors, the pathway from ligand
stimulation to SIRP α tyrosine phosphorylation is mediated by similar molecules.
One of these is likely to be a src-family kinase, because PP1 is a src-family kinase
inhibitor.  Although most inhibitors exhibit a degree of non-specificity, and using
inhibitors to identify specific proteins must be approached with caution, an inhibitor
can very effectively eliminate a candidate, as in this experiment.  Although
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activation of the EGFR kinase activity certainly triggers SIRP α tyrosine
phosphorylation, it is not inhibited by PP1.  Because PP1 inhibits EGF-induced
SIRP α tyrosine phosphorylation, the experiment eliminates the EGFR as the
kinase that directly phosphorylates SIRP α.
Experimental evidence clearly shows here that the kinase or kinases that directly
phosphorylate SIRP α are sensitive to PP1, a src-family kinase inhibitor, but that c-
src and c-fyn are probably not the kinases that directly phosphorylate SIRP α in
this system.  On the contrary, overexpression of kinase-inactive c-src and c-fyn
appear to induce tyrosine phosphorylation of SIRPs and this begs some
explanation.  It may be due to an adaptor function of src-family kinases.  Kinase-
independent functions of src-family kinases are known.  Fgr, another src-family
kinase, associates with SIRP α  in macrophages and inhibits macrophage
phagocytosis independently of its tyrosine kinase activity86.  It is also mentioned
that Fgr does not phosphorylate SIRP α and may therefore act as an adaptor
molecule.  Lck, another src-family tyrosine kinase enhances CD3-mediated
signalling by a kinase-independent mechanism that may involve the SH2 domain
of Lck 42 although the mechanism is unknown.  All src-family kinases possess an
SH2 domain so the adaptor function of src-family kinases in SIRP α tyrosine
phosphorylation is feasible.  A model would be that the src-family kinase recruits
directly or indirectly another PP1-sensitive kinase that phosphorylates SIRP α, and
downregulates its activity by phosphorylating an inhibitory residue on that
molecule.  Tyrosine kinases that are inactivated by tyrosine phosphorylation
include the src-family kinases themselves 87, Syk88,89 and possibly others.  It is
well-established that src-family kinases phosphorylate Syk, but instead of inhibiting
Syk, they enhance its activity greatly.
Src-family kinases may also have a role in activating a phosphatase that is able to
maintain SIRP α in a dephosphorylated condition.  It also cannot be discounted
that the kinase that phosphorylates SIRP α is not a src-family kinase but is still
inhibited by PP1. 
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6.3 The SIRP β/DAP12/Syk multiprotein complex
Figure 40  The SIRP β/DAP12 complex.  SIRP β associates constitutively with the dimeric
transmembrane adaptor protein DAP12 via an interaction in the transmembrane domain involving
two oppositely charged amino acids.  The tyrosine phosphorylated  ITAM motifs of DAP12 associate
with the SH2 domains of the cytosolic Syk tyrosine kinase.  Signalling through this complex may
have a positive influence on cellular survival.    SIRP α may be able to inhibit signalling via this
complex.
Evidence is provided here that SIRP β participates as a member of a multiprotein
complex with DAP12 and that Syk is involved in that complex.  Biochemical
106
evidence suggests that it may be a key mediator in signalling processes conducted
via this complex.  There is further evidence from studies with NIH3T3 cells
overexpressing SIRP β/DAP12, that this complex is involved in the regulation of
induced cell death, albeit through an as-yet unknown mechanism. With respect to
the transformed cellular phenotype, SIRP β/DAP12 may here be in opposition to
the inhibitory role ascribed to SIRP α.
6.3.1 Association of SIRP β with DAP12
The discovery of the association between SIRP β1 and DAP12 has placed SIRP β,
within the emerging family of 'Inhibitory Activating Receptors (IARs)'70 54. This
group of transmembrane receptors have structural similarity to SIRP β.  These
molecules have no intracellular domain and rely on the transmembrane association
with another molecule for their ability to transduce a signal3.  Two such adaptor
molecules so far exist.  These are DAP1290, also known as KARAP91-94, and
DAP10 95, which is also called KAP1096.  The antigen receptor FcεRI, the ζ−chain
of the CD3 complex and the Ig α/β heterodimeric subunits of the B-cell receptor
(BCR) complex are also related to this pair of molecules97.
DAP12 exists as a homodimer and possesses one ITAM motif6,7,98 per monomer.
Each ITAM motif contains two tyrosines that can be inducibly phosphorylated.
Current opinion suggests that this is catalysed by a src-family kinase.
Phosphorylation of both tyrosines in the ITAM provides a binding site for Syk, a
cytosolic tyrosine kinase critical for antigen receptor signalling99.  Both
SIRP β1 and DAP12 have a charged amino acid in their transmembrane domain.
SIRP β1 has a positively charged lysine, and DAP12 has an aspartic acid residue,
that is negatively charged.  This type of association was observed by Lanier in
1998 90, where oppositely charged transmembrane amino acids were shown to be
essential for the association between DAP12 and KIR2DS2, another IAR that is a
member of the Killer Inhibitory Receptor(KIR) family3,100.  NKG2D is another KIR
that associates with DAP12101.  SIRP β1 presumably interacts with DAP12 in a
similar way.
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Numerous molecules belonging to the SIRP β subtype have been discovered1, and
other molecules of the inhibitory receptor superfamily that resemble SIRP β in
structure also associate with DAP12 102 103.  It has been reported that DAP12 is
expressed ubiquitously in both haematopoietic and non-haematopoietic cells,
particularly in epithelial and neural cells 93.  Northern blot analysis of DAP12
suggests that it has a more restricted expression than SIRP β, which is expressed
over a broad spectrum of different cell lines (A. RuscheI and I. Sures, respectively,
unpublished observations).  This means that either there are other molecules
similar to DAP12 forming complexes with SIRP β molecules, or SIRP β has a
second role that it can perform alone.  One such candidate molecule, DAP10 (also
known as KAP10) 96 95 has been discovered to associate with certain other IARs in
a similar fashion to the SIRP β/DAP12 complex, but instead of an ITAM, DAP10
has a YXXM motif in its intracellular domain.  The YXXM motif binds the SH2
domain of the p85 regulatory subunit of phosphoinositol-3 kinase (PI-3K).  Two
other molecules with similar characteristics, CD3ζ and FcεRI can be included with
DAP12 and DAP10 to compose a small family.  It is tempting to speculate that
these proteins associate promiscuously with any IAR to produce a highly adaptable
system of receptor generation. In this system the specificity for an extracellular
ligand could be modified by the choice of the activating receptor subunit, while the
signal transducing effect would be decided by the cytoplasmic proteins brought to
the complex by the choice of DAP12-type receptor.  Recent evidence suggests,
however, that there is at least some degree of specificity generated by the
transmembrane domain of the DAP12-type protein for its SIRP β-like activating
receptor101.
6.3.2 The Syk tyrosine kinase as a member of the SIRP β/DAP12
complex
The association of Syk to DAP12 potentially links the SIRP β/DAP12 complex to
numerous established downstream signalling mechanisms.  Syk has roles in many
classical signal transduction pathways and is well studied through its involvement
in B-cell receptor (BCR) complex signalling via the Igα/Igβ subunits.
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Phosphorylation by the Syk kinase activates PLCγ directly, triggering calcium
mobilisation through the second messenger IP3 and activating NFκB via
diacylglycerol (DAG).  Syk also activates PI-3K, which, amongst many other
effects, activates protein kinase B (or Akt), inhibiting apoptosis via the Bcl/Bax
family.  Syk associates to the multidomain adaptor protein Vav, which utilises Rho-
family GTPases to control actin reorganisation, eliciting cell movement.  Vav also
modulates the p38 MAPK/JnK protein kinase pathway, and lastly the ERK/MAP
kinase activation can also be affected by Syk activation of ras 104.  A complex that
recruits and controls the activation of Syk therefore has the potential to regulate
important cellular processes, such as cell activation, proliferation, movement and
apoptosis.
Src-family kinases are thought to be involved in tyrosine phosphorylation of DAP12
and probably activation of Syk tyrosine kinase, for example Lyn is essential for full
activation of Syk in B cell signalling through the BCR104.  The complex of
phosphorylated proteins that surrounds immunoprecipitated DAP12-GST is
suggestive of an activating complex, and may be a sign that overexpression or
more of the pathways listed above are being utilised.
6.3.3 Similarities between SIRP β/DAP12/Syk and SIRP α/SHP-2/1
complexes
Revealing similarities between Syk and the SHP-2 tyrosine phosphatase can be
seen when they are compared.  Each molecule exists in a family of two members
with one other single, 'sister' molecule which is highly-related in sequence and
structure: ZAP-70 in the case of Syk, and SHP-1 in the case of SHP-2.  Although
SHP-1 is present in some non-haematopoietic cell types, both ZAP-70 and SHP-1
are thought to be principally expressed in haematopoietic lineages, while Syk and
SHP-2 are far more broadly distributed.  Both Syk and SHP-2 are cytosolic
molecules with two SH2 domains located at the N-terminal of the molecule
followed by the catalytic region.  Neither are constitutively localised at the
membrane, but can be recruited to the membrane by intermolecular interactions
with proteins containing phosphotyrosine-based motifs.  Syk is recruited to ITAM
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motif-containing proteins while SHP-2 is recruited to ITIM motif-containing proteins.
Functional studies of SHP-2 are surprising, because when studied in isolation, it
appears to have a positive role in signal transduction37, while at the same time, its
recruitment to the cell surface by SIRP α is essential for the inhibitory role
conferred upon SIRP α1.  Similarly, Syk has been long understood to play a
leading part in cellular activation through immunoreceptors, however a recent
paper reports its role as a tumour suppressor and inhibitor of cell proliferation in
breast cancer105.  It may be that these eccentric molecules confer either positive or
negative roles, dependent upon their subcellular localisation.  Lastly, when one
compares the associated SIRP α/SHP-2 complex to that of SIRP β/DAP12/Syk,
they look schematically similar, with the exception that the SIRP β/DAP12 complex
is likely to be composed of two SIRP β and two DAP12 molecules, while SIRP α
may only be a monomer.  Since overexpression of SIRP α is able to inhibit the
activity of Syk in vitro, it may be that the two complexes are intimately twinned, and
it is tempting to propose their participation in a common mechanism, e.g. to
modulate a signalling receptor complex, maybe localised to a raft.
6.4 Membrane translocation of SIRP β/DAP12 and
stabilisation of expression
To discuss this section it is first necessary to be clear that there were two different
levels of overexpression that produced different yet complementary effects.
Rather than being contradictory to each other these effects are informative when
the appropriate model is applied.  When the pLXSN or pIRES vector system was
used, the promoter that expressed the cDNA was the 5’ LTR of the retrovirus.
Although this overexpresses a desired construct, it is a much weaker promoter
than the CMV promoter in the pCDNA3 vector.    If a strong, CMV-driven
expression system was used instead of a weaker one, not only would more protein
be visible in the cell, but if it was trafficked to other areas in the cell, or even
secreted, higher expression would favour its localisation closer to the source of
protein synthesis.  For SIRP β and DAP12 this would be the ER because they both
have secretory signal peptides.
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It is surprising to discover that overexpression of DAP12 at the plasma membrane
requires co-overexpression of SIRP β, but remarkably, a search of the literature
can find other similar examples amongst the immunoglobulin superfamily.
Components of the pre-BCR complex are conditionally assembled in the ER before
being transported to the plasma membrane.  Reth (1990)106 showed that the
Ig α/Ig β heterodimeric component of the B-cell receptor complex is required for
transport of the entire B-cell receptor complex to the surface of the cell.  The T cell
receptor complex is not expressed at the surface of the T-cell without coexpression
of CD3ζ and vice versa 107.  Both CD3 ζ and Ig α/Ig β are similar to DAP12
because they are ITAM motif-containing transmembrane dimers with little
extracellular domain.
Assisted DAP12 transport to the cell membrane has now been very convincingly
proven by a daring expression cloning-style screen.  Cells stably overexpressing
an N-terminally epitope-tagged DAP12 were transfected with an expressed cDNA
library and sorted for the presence of the tag at the plasma membrane surface.
Sequencing the plasmids from the ‘tag-positive’ cells successfully pulled out
SIRP β-type activating receptors from the library.  SIRP β1 itself was among
them70.
6.4.1.1 Translocation of DAP12 to tyrosine kinases
Sodium pervanadate treatment inhibits endogenous tyrosine phosphatases
surrounding DAP12.  This induces DAP12 tyrosine phosphorylation that recruits
endogenous Syk tyrosine kinase to DAP12.  This is notably enhanced following
overexpression of SIRP β1.  Because SIRP β1 escorts DAP12 to the plasma
membrane, the difference in DAP12-GST tyrosine phosphorylation after SIRP β1
overexpression is probably because of DAP12 translocation. This is therefore
because SIRP β1 escorts DAP12 to the cell membrane where it comes into
proximity with the kinases that are responsible for its activation.  These kinases are
therefore likely to be restricted to the cell membrane and not clustered around
DAP12 before it reaches the membrane.  Candidates would be the src-family
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kinases, since they are permanently membrane-localised by myristoylation, and
already implicated in the activation of other molecules that have ITAM motifs88,108.
6.4.1.2 SIRP β as a potentially secreted protein
When SIRP β1 was overexpressed in NIH3T3 or HEK293 cells protein could be
found in the cell culture medium.  When DAP12 was expressed together with
SIRP β1 the amount of SIRP β1 in the medium was depleted but was increased in
the cell lysates. There is even more SIRP β in the medium when a stronger
promoter system is used.  If the amount of secreted SIRP β increases with
expression, it is probably not proteolytically ‘shedded’.  If this were the case one
would expect the sheddase activity to be overwhelmed by the substrate (SIRP β),
and protein would accumulate at the plasma membrane.  SIRP β-GFP is not seen
in the membrane, so it either does not reach the membrane or it leaves the cell
altogether.  There are significant quantities of SIRP β in the supernatant when it is
overexpressed in pCDNA3 meaning that it probably leaves the cell.  Since it is
hardly visible in the cell when expressed without DAP12 and under retroviral LTR
control, it might mean that SIRP β  has a second role as a secreted molecule in the
absence of DAP12.  If SIRP β really were a secreted protein, it would explain why
it is difficult to detect in cell lysates in western blot when not overexpressed.
SIRP β1 cannot be detected in immunofluorescence at weaker LTR-driven
expression when expressed alone, but when DAP12 is expressed SIRP β is clearly
detectable at the plasma membrane.  If SIRP β were secreted DAP12 would in this
context be acting as a membrane anchor that would convert SIRP β from a
secreted protein to one subunit of a transmembrane complex.  Therefore DAP12
would modulate both the localisation and function of SIRP β.  Interestingly, a
SIRP β isoform has been recently found without the positively charged amino acid
that would be essential for association with DAP12 109.  In the absence of a
membrane-anchoring coreceptor, this isoform may be targeted unconditionally to
the supernatant.
If SIRP β molecules are potentially secreted, the SIRP family could be likened to
semaphorins.  This is a family of neuronal and haematopoietic receptors made up
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of secreted forms as well as membrane-bound forms.  The membrane bound
forms in some cases have cytoplasmic domains that can participate in signal
transduction.  The secreted forms have been shown to have roles in axon
guidance, with both chemoattractant and chemorepellent qualities.  Semaphorins
have also recently been discovered in haematopoietically-derived cells, and may
also therefore have a role in lymphocyte adhesion/migration 110 111.  The extreme
unwillingness of the SIRP β1-GST fusion protein to act in cell adhesion, discussed
earlier, may indicate a chemorepellent quality.
However, although it is tempting to speculate upon the possible role of SIRP β as a
secreted chemoattractant (or indeed repellant), the hypothesis requires sturdy
biological evidence to support it.  Without this evidence, a role for SIRP β in the
extracellular milieu cannot be addressed as more than a feasibility.
6.4.2 SIRP proteins in rafts, and/or caveolae
SIRP family members were found in fractions enriched with caveolin-1 that
separated from plasma membrane fractions in ultracentrifugation experiments.
Caveolae and rafts are structures in the plasma membrane that are unusually rich
in cholesterol, and caveolin-1 is a marker protein for the caveolus.  Caveolae are
distinguishable from rafts so far only by the presence of caveolin-1.  They were
originally thought to be involved in clathrin-independent endo- or exocytosis, but
after the techniques to purify rafts were improved, they were shown to contain a
wide variety of proteins, many of them involved in signal transduction.  Molecules
of particular interest that have been found in caveolae include the src-family
kinases, RTKs such as the EGFR, PDGFR and insulin receptors, G protein-
coupled receptors, adaptor proteins such as SHC and Grb2, as well as PI-3K and
MAP kinases.  They are now thought to house, spatially organise, and even aid in
the assembly of signal transduction complexes.  They possibly also separate
complexes from each other to avoid signalling chaos through unwanted cross-talk.
Scientists studying the function of the trans-synaptic eph – ephrin signalling system
used a raft model to propose that both halves of the complex on either side of the
synapse are spatially arranged as though positioned on a platform.
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Like SIRP molecules, the ephrins are a family of membrane proteins that have two
subtypes.  The A-type ephrins are fastened to the outside of the membrane by a
GPI  anchor and the B-type ephrins are transmembrane proteins.   A-type ephrins
are thought to associate with an as yet unknown transmembrane protein.  This
anonymous mediator recruits src-family kinases e.g. c-fyn to the A-type ephrin
complex.  The B-type ephrins have a cytoplasmic domain that binds tyrosine
kinases when it is tyrosine phosphorylated.  These associations are at least partly
responsible for co-ordinating the cell adhesion and cytoskeletal rearrangement
necessary for axon guidance.
The ligands for the A- and B- type ephrins on the surface of the neighbouring cell
RTKs are the eph receptors, which are RTKs.  The ephrins contact the ephs
across the synapse and bring the ephs into sufficiently close contact with each
other to activate them by transphosphorylation.  This triggers a signal transduction
cascade that motivates a chemotactic response by the other cell.  Hence, a bi-
directional signal transduction response is set up at a localised position at the cell
surface.
Useful comparisons can be drawn between ephrins and SIRPs.  SIRP α molecules
are scaffold proteins residing at the membrane that can associate with certain
receptors 23and a variety of tyrosine kinases and adaptor proteins.  SIRPs also
exist in rafts, and SIRP α has at least one intercellular ligand.  Although SIRP β is
not known to be GPI linked, it is anchored to the membrane by another
transmembrane protein that associates with Syk and maybe other tyrosine
kinases.  It may be possible to apply a similar model to the SIRPs in the future.  A
bi-directional SIRP α/CD47 signalling mechanism in the retina has already been
reported75.
The discovery of SIRP α in the raft fits quite well with its proposed role as a
scaffold protein.  One of its functions could be to recruit necessary proteins to the
signal transduction complexes in the raft.  One such a protein may be SHP-2,
because its localisation is definitely influenced by SIRP α tyrosine phosphorylation.
There may also be a role here for the different family members of SIRP α subtype
in recruiting molecules to specific receptors.  The single amino acid differences
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between SIRPs might make them different enough to define the specificity of a
receptor interaction.
6.5 Stimulation of the SIRP β/DAP12 complex with mAb
B1D5C3
The mAb B1D5C3 antibody was used to activate the function of the SIRP β/DAP12
complex by SIRP β1 coligation.  Although the antibody bound clearly to SIRP β1 at
the cell surface, the treatment gave only a weak tyrosine phosphorylation of
DAP12-GST that may even have been independent of the antibody.  The possible
reasons for this should be discussed.  The affinity of the antibody for SIRP β1 is
unlikely to be a reason, because it bound very quickly to the DAP12-GST complex.
However, it may be that the antibody binds to an epitope that is present more than
once on SIRP β1 and therefore is less efficient at coligating one SIRP β molecule
with another.  A weak coprecipitation of Syk with DAP12-GST was visible after one
hour.  This may mean that longer incubations might be necessary for better
activation, giving the process a time frame that rather resembles the formation of a
large cellular structure such as a focal adhesion than a typical receptor-ligand
interaction.
Activation of signal transduction through the SIRP β/DAP12 complex through
coligation has reported by other researchers.  This activation resulted in MAPK
activation and cellular activation in myeloid cells70.  This data names SIRP β as an
Inhibitory Activating Receptor (IAR) that opposes the inhibitory effect that
SIRP α has on cell activation.  Moreover it hints at a possible complementary
relationship between SIRP α and SIRP β in the modulation of a signal.
6.6 Regulation of the SIRP β/DAP12 complex by SIRP α
Experiments presented here have suggested that SIRP α complexes with protein
kinases both dependent on and independent of its own tyrosine phosphorylation.
Evidence is also provided that the complex associated with SIRP α can inhibit
SIRP β/DAP12/Syk activation, and that this may involve tyrosine kinases.
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6.7 Kinases associated with SIRP α
Two tyrosine kinases are known to associate in vitro with SIRP α.  These are
CSK20 and PYK223.
CSK is a protein tyrosine kinase that shares a strong degree of homology to the
src-family tyrosine kinases, although it is not a membrane anchored protein and
does not possess the c-terminal inhibitory tyrosine (Y527 in c-src).  One function of
CSK is, in fact, to inhibit src-family tyrosine kinases by phosphorylating their c-
terminal tyrosine42.  A conformational change caused by an intramolecular
interaction between the SH2 domain of the src-kinase and this phosphotyrosine
shuts down the kinase activity.  The kinase activity that is dependent upon
SIRP α tyrosine phosphorylation can phosphorylate the Lck c-terminal tyrosine so
CSK is as a candidate for this activity.
PYK2 is a comparatively new tyrosine kinase that shares significant sequence
homology with focal adhesion kinase (FAK).  It is expressed prominently in
haematopoietic cells and in the brain, fitting that of the SIRP family.  While FAK
plays an important role in signalling through integrins112, the role of PYK2 is as yet
not so clear.  PYK2 associates to SIRP α independently of SIRP α tyrosine
phosphorylation, although the nature of the association is not precisely
characterised22.  Enolase was phosphorylated by a tyrosine kinase activity
independent of SIRP α tyrosine phosphorylation, but there are no reports of PYK2
being able to phosphorylate enolase, the other exogenous substrate used to detect
kinase activity.
Enolase is an established substrate of src-family kinases often used in in vitro
kinase assays, and therefore a src-family kinase may associate constitutively with
SIRP α molecules.  This could provide a role for the ‘proline-rich’ region near the
C-terminal end of SIRP α because all src-family kinases possess an SH3 domain.
Although the SH3 domain is involved in intramolecular interactions, it is displaced
by proline-rich regions belonging to other molecules87.  This suggests it could also
have adaptor function.  Src-family kinases have not yet been shown to be
physically associated to SIRP α, but their involvement with SIRP α is often
suggested.
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6.7.1 Inhibition of SIRP β complex by SIRP α
Overexpression of SIRP α inhibited the activity of a molecule associated to DAP12
that was probably Syk.  At the same time this molecule was phosphorylated.  It
suggests that SIRP α brings a kinase to the DAP12 complex that inhibits the
signalling that is dependent upon Syk activity.  Syk does not have a c-terminal
inhibitory tyrosine in the style of a src-family tyrosine kinase, but src-family kinase
activity is required for full activation of Syk in B cell activation through the BCR.  If
src-family kinases were involved in the activation of Syk bound to DAP12, src-
family kinase inhibition would also inhibit Syk.  CSK brought to DAP12 by SIRP α
would therefore have the potential to inhibit Syk.  There are also suggestions that
CSK can inhibit the tyrosine phosphorylation of DAP12-GST.  Since src-family
kinases also likely phosphorylate DAP12, CSK may have a double role.  The
similar (albeit weaker) effect of PYK2 on DAP12 tyrosine phosphorylation in the
same experiment is harder to explain but would also suggest that the wild type
PYK2 has a negative effect on DAP12 tyrosine phosphorylation.
The structure of SIRP α closely resembles other inhibitory receptor superfamily
members.  Although the sequences are highly divergent between SIRPs and for
example, KIRs, Fcγ receptors and other subfamilies, the ITIMs maintain their
integrity. ITIM motif-containing Inhibitory receptor superfamily members have been
shown to have suppressive effects on cell activation in cells from a haematopoietic
lineage, primarily NK cells, T-cells and B-cells2.  Where possible, these inhibitory
effects were shown to be directed upon the positive signals generated by receptors
containing ITAM motifs, for example the BCR Ig α and Ig β, CD3 ε, CD3 γ, TCR ζ,
and Fc εRl γ. The ability of SIRP α to have a similar effect on ITAM containing
receptors would appear to extend the issue. Coligation of a chimera containing the
intracellular portion of SIRP α fused to the extracellular domain of the high affinity
IgE receptor FcεRl inhibits tyrosine phosphorylation and cell activation through IgE
stimulation of FcεRl.  The chimera becomes tyrosine phosphorylated during
coligation and binds SHP-1 and SHP-2 113.  This means that SIRP α has the
potential to deliver an inhibitory signal to complexes involving receptors with ITAM
117
motifs, and implies an ITIM-dependent mechanism relating SIRP α to other ITIM-
containing receptors in haematopoietic cells.
6.8 Biological effects of SIRP β/DAP12 overexpression in
NIH3T3 cells
Overexpression of SIRP β/DAP12 in NIH3T3 cells leads to an inhibition of induced
cell death. The word ‘apoptosis’ is sparingly used because inter-histone DNA
cleavage or caspase activation were not investigated.  However, nuclear DNA
visualisation using the fluorescent DAPI stain showed that TNFα induced nuclear
condensation, and the cell death that results from TNFα treatment is generally
accepted to be apoptosis and not necrosis.
The second phenotype produced by the SD469 cells was the increased rate of
acid production by the cells as well as glucose uptake, both observations reflecting
enhanced glycolysis.  This is of interest, because resistance to apoptosis and
enhanced glycolysis are two phenomena that are both hallmarks of cellular
transformation and are characteristic of tumour cells.
Mechanisms leading to apoptosis are numerous and are better discussed
elsewhere, but one relevant mechanism would be through PI-3K, because it is a
substrate of Syk that is activated by tyrosine phosphorylation. Active PI-3K then
activates Akt, a protein kinase which is an inhibitor of apoptosis thought to have
effects upon the Bcl/Bax/Bad family of proteins114.  Akt also leads to upregulation
of the GLUT1,3 and 4 glucose transporters and activates PFK2.  Both phenomena
are factors that lead to enhanced glycolysis.  Therefore, Akt activation may be one
way by which both enchanced glycolysis and apoptosis resistance can be linked to
SIRPβ/DAP12.  However, experiments with PI-3K inhibition using Wortmannin
were not able to show that either phenotype was dependent on PI-3K.  Therefore,
either the conditions of inhibition were not sufficient to properly inhibit PI-3K or the
cells use different pathways to achieve the observed phenotype.
It would be interesting to know whether SIRP β/DAP12-mediated resistance to cell
death and enhanced glycolysis are linked.  Levitski 115,116 has noticed that inhibition
of apoptosis and enhanced glycolysis are connected through src-family tyrosine
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kinases.  PP1 treatment at higher concentrations also inhibited the resistance to
cell death in SD469 cells.  Although the PP1 concentration used was too high to
implicate src-family kinase activity, it would be interesting to know if PP1 also
affected glucose uptake to link the two phenotypes mechanistically.
Therefore, two observations, a resistance of induced cell death and evidence of
enhanced glycolysis in NIH3T3 cells overexpressing SIRP β/DAP12 in NIH3T3
cells have provided two hints that SIRP β/DAP12 may be factors that contribute to
cell transformation.  These proceed through as yet undefined pathways, but it
would be too early to rule out Akt as a potential player and further experiments to
define the mechanism might prove worthwhile.
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8 Summary
The SIRPs are a recently discovered family of glycoproteins comprising more than
30 members belonging to the immunoglobulin superfamily.  The two different
structural subtypes, termed SIRP α and SIRP β, are distinguished by the presence
or absence of a cytoplasmic domain, respectively.  SIRP α1, the first member of
the family to be purified, had been characterised as a negative regulator of signal
transduction, and transformation assays had suggested that it also had tumour
suppressive effects.  Little or nothing is known about the possible function of either
the other SIRP α homologues or the members of the SIRP β subtype.
The Ig-like domains possessed in the extracellular domains of all SIRPs suggest
they have binding partners outside the cell.  Cell adhesion experiments using the
extracellular domains of SIRP family members showed that SIRP α have adhesion
molecule properties.  This led to the identification of CD47 as one ligand for
SIRP α, performed in collaboration with others21and confirmed here.  Furthermore,
these experiments suggested that SIRP α molecules have at least one further
unknown ligand that is not CD47.
The discovery that SIRP α was a cell adhesion molecule with a regulatory role in
signal transduction was expanded by in vitro kinase experiments and experiments
with inhibitors of tyrosine kinases.  They showed that SIRP α associated with more
than one kinase activity, and that cytosolic tyrosine kinases, probably of the src-
family, were necessary for SIRP α to regulate tyrosine phosphorylation of a
receptor.
In contrast to SIRP α molecules, proteins belonging to the SIRP β subtype remain
uncharacterised.  Therefore a large part of this work concentrates on the SIRP β
subtype, its associated proteins, localisation and possible function in a cell.
In vitro association experiments revealed that SIRP β is part of a multiprotein
complex at the cell membrane, where SIRP β1 interacted with DAP12, an adaptor
protein with a transmembrane domain.  DAP12 linked SIRP β to a cytosolic
tyrosine kinase identified as Syk confirmed by western blot and PCR from cDNA
preparations of the cell lines used in these experiments.  The interaction of Syk
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with the complex required the tyrosine phosphorylation of DAP12.  Coligating SIRP
β molecules at the membrane with a SIRP β-specific monoclonal antibody
recruited Syk to DAP12 where it could be activated by treatment with sodium
pervanadate.  In vitro kinase assays detected several unknown phosphorylated
proteins associated with SIRP β/DAP12/Syk when Syk was activated that may
represent signalling molecules operating downstream of the complex.
Cotransfection experiments showed that SIRP α complexed with kinase activities
that enabled it to inhibit both DAP12 tyrosine phosphorylation and Syk kinase
activity.  This suggested that both complexes at some point operated in close
contact, so experiments were carried out to localise SIRP proteins in the cell.
Fractionation experiments discovered that SIRP α and possibly SIRP β could be
detected in fractions that contained GPI microdomains, or caveolae.  Similar
investigations with the SIRP β1/DAP12 complex revealed that DAP12 was
dependent upon SIRP β for its direction to the plasma membrane where it was
activated by tyrosine kinases.  Membrane localisation of SIRP β was similarly
reliant upon DAP12 expression, however, further experiments suggested that
SIRP β may be secreted from the cell in the absence of DAP12.
To address the potential role of SIRP β1/DAP12 complex in signal transduction,
cell lines overexpressing SIRP β and DAP12 were analysed.  Cell death assays
suggested that the SIRP β1/DAP12 complex was a negative regulator of induced
cell death, and that tyrosine kinases might be involved in this regulation.  Cells
overexpressing SIRP β and DAP12 showed an enhanced rate of acid production,
corresponding to an enhanced rate of glucose metabolism.  These observations
suggests that, SIRP β1/DAP12 overexpression may be a factor that contributing to
a transformed phenotype, works in opposition to SIRP α molecules.
This work views the SIRPs as components of a cluster of different proteins at the
cell membrane that recruit and use other cytosolic proteins, among them tyrosine
kinases and phosphatases. It shows that SIRP α molecules may collaborate with
SIRP β family members to modulate the signals generated by other receptors in
signal transduction.  This modulation may influence aberrant cellular processes
that lead to disease.
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